| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | PSG1 PSG2 PSG3 PSG6 SLC38A9 SLC10A6 PSG8 SLC23A1 ABCC1 ABCC11 GRIA2 GRIK2 GRIK3 SLC6A5 SLC36A3 | 3.29e-08 | 207 | 240 | 15 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | PSG1 PSG2 PSG3 PSG6 SLC38A9 SLC10A6 PSG8 SLC23A1 ABCC1 ABCC11 GRIA2 GRIK2 GRIK3 SLC6A5 SLC36A3 | 3.51e-08 | 208 | 240 | 15 | GO:0005342 |
| GeneOntologyMolecularFunction | glycolipid binding | 1.14e-07 | 49 | 240 | 8 | GO:0051861 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 1.35e-07 | 34 | 240 | 7 | GO:0015125 | |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 4.41e-07 | 14 | 240 | 5 | GO:0005130 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.07e-06 | 29 | 240 | 6 | GO:0035325 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 2.66e-06 | 73 | 240 | 8 | GO:0170055 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | PSG1 PSG2 PSG3 PSG6 SLC38A9 SLC10A6 PSG8 SLC23A1 ABCC1 ABCC11 GRIA2 GRIK2 GRIK3 SLC6A5 SLC36A3 | 2.83e-06 | 293 | 240 | 15 | GO:0008514 |
| GeneOntologyMolecularFunction | calcium ion binding | PRSS3 GALNT3 SPOCK1 DNER FSTL4 SPOCK2 MELK SVEP1 RYR1 BMP1 HMCN2 NRXN1 HSPG2 STAB2 DSC2 BCL2L10 SRR EDIL3 SNED1 EYS PPP3CA PPP3CB TKT NCAN MACF1 | 4.22e-06 | 749 | 240 | 25 | GO:0005509 |
| GeneOntologyMolecularFunction | lipid transporter activity | ABCA1 PSG1 PSG2 PSG3 PSG6 ANO5 SLC10A6 PSG8 PLEKHA8 ATP8B3 ABCC1 ABCC11 | 4.68e-06 | 196 | 240 | 12 | GO:0005319 |
| GeneOntologyMolecularFunction | GPI anchor binding | 6.78e-06 | 23 | 240 | 5 | GO:0034235 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.29e-05 | 90 | 240 | 8 | GO:0008028 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | LAMA1 SPOCK2 CHI3L1 SSPOP HMCN2 DMBT1 HSPG2 FRAS1 LAMA4 LAMB1 EDIL3 | 1.79e-05 | 188 | 240 | 11 | GO:0005201 |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 2.09e-05 | 70 | 240 | 7 | GO:1901618 | |
| GeneOntologyMolecularFunction | filamin binding | 2.26e-05 | 29 | 240 | 5 | GO:0031005 | |
| GeneOntologyMolecularFunction | kainate selective glutamate receptor activity | 3.34e-05 | 6 | 240 | 3 | GO:0015277 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 8.17e-05 | 149 | 240 | 9 | GO:1990782 | |
| GeneOntologyMolecularFunction | complement component C3b receptor activity | 1.44e-04 | 2 | 240 | 2 | GO:0004877 | |
| GeneOntologyMolecularFunction | complement component C4b receptor activity | 1.44e-04 | 2 | 240 | 2 | GO:0001861 | |
| GeneOntologyMolecularFunction | kinase binding | CEBPA PSG1 PSG2 PSG3 PSG6 PSG7 ADCY6 GAB2 BTG1 PKD1 MAP3K11 PSG8 FLNA TTC28 NRTN CAMK2B GRIA2 NBEA TRIM68 CSK LRBA TBR1 MAPK4 MUSK MAP3K2 | 2.79e-04 | 969 | 240 | 25 | GO:0019900 |
| GeneOntologyMolecularFunction | complement component C4b binding | 4.28e-04 | 3 | 240 | 2 | GO:0001855 | |
| GeneOntologyMolecularFunction | complement receptor activity | 5.66e-04 | 14 | 240 | 3 | GO:0004875 | |
| GeneOntologyMolecularFunction | metalloendopeptidase inhibitor activity | 8.55e-04 | 16 | 240 | 3 | GO:0008191 | |
| GeneOntologyMolecularFunction | protein kinase binding | PSG1 PSG2 PSG3 PSG6 PSG7 ADCY6 GAB2 PKD1 MAP3K11 PSG8 FLNA NRTN CAMK2B GRIA2 NBEA TRIM68 CSK LRBA TBR1 MAPK4 MUSK MAP3K2 | 8.87e-04 | 873 | 240 | 22 | GO:0019901 |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 1.03e-03 | 17 | 240 | 3 | GO:0004970 | |
| GeneOntologyMolecularFunction | ligand-gated sodium channel activity | 1.22e-03 | 18 | 240 | 3 | GO:0015280 | |
| GeneOntologyMolecularFunction | calmodulin-dependent protein phosphatase activity | 1.40e-03 | 5 | 240 | 2 | GO:0033192 | |
| GeneOntologyMolecularFunction | calcium- and calmodulin-responsive adenylate cyclase activity | 1.40e-03 | 5 | 240 | 2 | GO:0008294 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | PSG1 PSG2 PSG3 PSG6 ZFYVE1 GAB2 PSG8 PLEKHA8 ARAP1 OGT WIPI2 | 1.61e-03 | 316 | 240 | 11 | GO:0035091 |
| GeneOntologyMolecularFunction | sphingolipid transporter activity | 1.68e-03 | 20 | 240 | 3 | GO:0046624 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 1.69e-03 | 105 | 240 | 6 | GO:0015171 | |
| GeneOntologyMolecularFunction | disulfide oxidoreductase activity | 1.74e-03 | 43 | 240 | 4 | GO:0015036 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 1.81e-03 | 144 | 240 | 7 | GO:0016798 | |
| GeneOntologyMolecularFunction | lipid binding | ABCA1 PSG1 PSG2 PSG3 PSG6 SLC38A9 LAMA1 ZFYVE1 MELK GAB2 PROM2 PSG8 DMBT1 SEC14L4 PLEKHA8 ARAP1 OGT LAMB1 TLR10 CD1B PPP5C CADPS2 WIPI2 | 1.92e-03 | 988 | 240 | 23 | GO:0008289 |
| GeneOntologyMolecularFunction | calmodulin binding | 1.92e-03 | 230 | 240 | 9 | GO:0005516 | |
| GeneOntologyMolecularFunction | cell adhesion mediator activity | 2.22e-03 | 76 | 240 | 5 | GO:0098631 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 3.70e-09 | 83 | 243 | 11 | GO:0002707 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation, classical pathway | 1.19e-08 | 8 | 243 | 5 | GO:0045959 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 1.77e-08 | 96 | 243 | 11 | GO:0002704 | |
| GeneOntologyBiologicalProcess | regulation of complement activation, classical pathway | 5.23e-08 | 10 | 243 | 5 | GO:0030450 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 8.49e-08 | 20 | 243 | 6 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response mediated by circulating immunoglobulin | 1.61e-07 | 12 | 243 | 5 | GO:0002924 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 4.00e-07 | 14 | 243 | 5 | GO:0070348 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation | 4.00e-07 | 14 | 243 | 5 | GO:0045916 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 5.94e-07 | 15 | 243 | 5 | GO:0070347 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 5.94e-07 | 15 | 243 | 5 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 5.94e-07 | 15 | 243 | 5 | GO:0002859 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 5.94e-07 | 15 | 243 | 5 | GO:1903387 | |
| GeneOntologyBiologicalProcess | regulation of complement activation | 6.05e-07 | 27 | 243 | 6 | GO:0030449 | |
| GeneOntologyBiologicalProcess | complement activation, classical pathway | 7.64e-07 | 44 | 243 | 7 | GO:0006958 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 8.56e-07 | 16 | 243 | 5 | GO:0038016 | |
| GeneOntologyBiologicalProcess | negative regulation of immunoglobulin mediated immune response | 8.56e-07 | 16 | 243 | 5 | GO:0002890 | |
| GeneOntologyBiologicalProcess | negative regulation of B cell mediated immunity | 8.56e-07 | 16 | 243 | 5 | GO:0002713 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 1.20e-06 | 17 | 243 | 5 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 1.20e-06 | 17 | 243 | 5 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 1.20e-06 | 17 | 243 | 5 | GO:0038158 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 1.22e-06 | 47 | 243 | 7 | GO:0015721 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 1.65e-06 | 18 | 243 | 5 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 1.76e-06 | 32 | 243 | 6 | GO:0045779 | |
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response | 2.21e-06 | 19 | 243 | 5 | GO:0002921 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | PSG1 PSG2 PSG3 PSG6 HMCN2 PKD1 PSG8 ROBO3 PLXNB3 SDK2 DSC2 ROBO2 | 2.36e-06 | 187 | 243 | 12 | GO:0007156 |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 2.46e-06 | 52 | 243 | 7 | GO:0031342 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 2.56e-06 | 34 | 243 | 6 | GO:0046851 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 3.80e-06 | 21 | 243 | 5 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 3.80e-06 | 21 | 243 | 5 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 3.80e-06 | 21 | 243 | 5 | GO:0002838 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | PSG1 PSG2 PSG3 PSG6 CD46 IL18RAP SVEP1 PSG8 CR1 CR1L CR2 CD1B PPP3CB | 4.02e-06 | 232 | 243 | 13 | GO:0002706 |
| GeneOntologyBiologicalProcess | cell junction organization | PSG1 PSG2 PSG3 PSG6 DNER SPOCK2 ITGB4 SVEP1 LRFN4 HMCN2 NRXN1 PSG8 PLXNB1 FLNA SDK2 LRFN1 OGT CAMK2B SLITRK4 CPEB3 NBEA PIP5K1C SEZ6L2 CSK NCAN MACF1 ROBO2 MUSK SEZ6L | 4.45e-06 | 974 | 243 | 29 | GO:0034330 |
| GeneOntologyBiologicalProcess | negative regulation of immune effector process | 4.58e-06 | 166 | 243 | 11 | GO:0002698 | |
| GeneOntologyBiologicalProcess | regulation of humoral immune response mediated by circulating immunoglobulin | 4.87e-06 | 22 | 243 | 5 | GO:0002923 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 4.87e-06 | 22 | 243 | 5 | GO:0030853 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 5.06e-06 | 38 | 243 | 6 | GO:2000345 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 6.16e-06 | 23 | 243 | 5 | GO:0002858 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 6.16e-06 | 23 | 243 | 5 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 7.71e-06 | 24 | 243 | 5 | GO:0002855 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 7.71e-06 | 24 | 243 | 5 | GO:2001214 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 7.71e-06 | 24 | 243 | 5 | GO:0002420 | |
| GeneOntologyBiologicalProcess | humoral immune response mediated by circulating immunoglobulin | 8.19e-06 | 62 | 243 | 7 | GO:0002455 | |
| GeneOntologyBiologicalProcess | female pregnancy | PSG1 PSG2 PSG3 PSG6 PSG7 KPNA6 ITGB4 HSPG2 COMT LAMB1 CR1 CR1L CSMD1 | 8.66e-06 | 249 | 243 | 13 | GO:0007565 |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 9.54e-06 | 25 | 243 | 5 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 9.54e-06 | 25 | 243 | 5 | GO:0002423 | |
| GeneOntologyBiologicalProcess | regulation of cell killing | 9.92e-06 | 147 | 243 | 10 | GO:0031341 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 1.25e-05 | 66 | 243 | 7 | GO:0010543 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 1.42e-05 | 27 | 243 | 5 | GO:0070344 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 1.59e-05 | 46 | 243 | 6 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 1.59e-05 | 46 | 243 | 6 | GO:0072574 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 1.72e-05 | 28 | 243 | 5 | GO:0034111 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 1.80e-05 | 47 | 243 | 6 | GO:0001911 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 1.80e-05 | 47 | 243 | 6 | GO:0034104 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 1.84e-05 | 70 | 243 | 7 | GO:0045124 | |
| GeneOntologyBiologicalProcess | complement activation | 1.84e-05 | 70 | 243 | 7 | GO:0006956 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated immunity | PSG1 PSG2 PSG3 PSG6 CD46 IL18RAP SVEP1 GAB2 PSG8 CR1 CR1L CR2 CD1B PPP3CB | 1.94e-05 | 309 | 243 | 14 | GO:0002703 |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 2.05e-05 | 29 | 243 | 5 | GO:2001212 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-1 production | 2.22e-05 | 72 | 243 | 7 | GO:0032692 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | PSG1 PSG2 PSG3 PSG6 LRFN4 HMCN2 NRXN1 PKD1 PSG8 ROBO3 PLXNB3 SDK2 DSC2 ROBO2 | 2.24e-05 | 313 | 243 | 14 | GO:0098742 |
| GeneOntologyBiologicalProcess | liver morphogenesis | 2.30e-05 | 49 | 243 | 6 | GO:0072576 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 2.88e-05 | 31 | 243 | 5 | GO:0010544 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 3.38e-05 | 32 | 243 | 5 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 3.38e-05 | 32 | 243 | 5 | GO:0060312 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 3.95e-05 | 33 | 243 | 5 | GO:2000252 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 3.95e-05 | 33 | 243 | 5 | GO:0030852 | |
| GeneOntologyBiologicalProcess | multi-organism reproductive process | PSG1 PSG2 PSG3 PSG6 PSG7 KPNA6 ITGB4 HSPG2 COMT LAMB1 CR1 CR1L CSMD1 | 4.30e-05 | 290 | 243 | 13 | GO:0044703 |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 4.42e-05 | 80 | 243 | 7 | GO:0046850 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 4.58e-05 | 34 | 243 | 5 | GO:0043116 | |
| GeneOntologyBiologicalProcess | multi-multicellular organism process | PSG1 PSG2 PSG3 PSG6 PSG7 KPNA6 ITGB4 HSPG2 COMT LAMB1 CR1 CR1L CSMD1 | 4.95e-05 | 294 | 243 | 13 | GO:0044706 |
| GeneOntologyBiologicalProcess | insulin metabolic process | 5.30e-05 | 35 | 243 | 5 | GO:1901142 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 6.72e-05 | 59 | 243 | 6 | GO:0045671 | |
| GeneOntologyBiologicalProcess | regulation of humoral immune response | 7.39e-05 | 60 | 243 | 6 | GO:0002920 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 7.39e-05 | 60 | 243 | 6 | GO:0030851 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | ILDR2 PSG1 PSG2 PSG3 PSG6 CD46 ITGB4 SVEP1 LRFN4 HMCN2 NRXN1 PKD1 PSG8 ROBO3 PLXNB3 FLNA SDK2 ZAN DSC2 LAMB1 VSIG10 CR1 PIP5K1C AQP4 PPP3CA STXBP6 CSK ROBO2 | 7.46e-05 | 1077 | 243 | 28 | GO:0098609 |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 9.04e-05 | 39 | 243 | 5 | GO:0045717 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 1.02e-04 | 40 | 243 | 5 | GO:0045953 | |
| GeneOntologyBiologicalProcess | platelet activation | 1.10e-04 | 158 | 243 | 9 | GO:0030168 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 1.12e-04 | 124 | 243 | 8 | GO:0001910 | |
| GeneOntologyBiologicalProcess | homotypic cell-cell adhesion | 1.12e-04 | 124 | 243 | 8 | GO:0034109 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 1.15e-04 | 41 | 243 | 5 | GO:0002716 | |
| GeneOntologyBiologicalProcess | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.27e-04 | 66 | 243 | 6 | GO:0002823 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 1.30e-04 | 42 | 243 | 5 | GO:0090330 | |
| GeneOntologyBiologicalProcess | platelet aggregation | 1.32e-04 | 95 | 243 | 7 | GO:0070527 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response | 1.32e-04 | 239 | 243 | 11 | GO:0050777 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 1.38e-04 | 67 | 243 | 6 | GO:0045601 | |
| GeneOntologyBiologicalProcess | regulation of tissue remodeling | 1.40e-04 | 128 | 243 | 8 | GO:0034103 | |
| GeneOntologyBiologicalProcess | bone resorption | 1.71e-04 | 99 | 243 | 7 | GO:0045453 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 1.81e-04 | 45 | 243 | 5 | GO:0048521 | |
| GeneOntologyBiologicalProcess | negative regulation of adaptive immune response | 1.90e-04 | 71 | 243 | 6 | GO:0002820 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | AHI1 PSG1 PSG2 PSG3 PSG6 PROM2 PSG8 DMBT1 HSPG2 STAB2 GRIA2 PIP5K1C TFR2 | 1.94e-04 | 337 | 243 | 13 | GO:0006898 |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 2.72e-04 | 49 | 243 | 5 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 2.76e-04 | 76 | 243 | 6 | GO:0042269 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 3.00e-04 | 50 | 243 | 5 | GO:0002834 | |
| GeneOntologyBiologicalProcess | synapse maturation | 3.00e-04 | 50 | 243 | 5 | GO:0060074 | |
| GeneOntologyBiologicalProcess | cell killing | 3.02e-04 | 307 | 243 | 12 | GO:0001906 | |
| GeneOntologyBiologicalProcess | lymphocyte mediated immunity | PSG1 PSG2 PSG3 PSG6 CD46 IL18RAP SVEP1 PSG8 C6 C7 CR1 CR1L CR2 CD1B PPP3CB | 3.02e-04 | 449 | 243 | 15 | GO:0002449 |
| GeneOntologyBiologicalProcess | synapse assembly | DNER SPOCK2 LRFN4 NRXN1 PLXNB1 SDK2 LRFN1 OGT SLITRK4 CPEB3 ROBO2 MUSK | 3.11e-04 | 308 | 243 | 12 | GO:0007416 |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 3.65e-04 | 80 | 243 | 6 | GO:0002715 | |
| GeneOntologyBiologicalProcess | behavior | AHI1 PSG1 PSG2 PSG3 PSG6 ADCY5 BTG2 NRXN1 KCNJ10 PSG8 ESPN COMT GALR3 CPEB3 LAMB1 GRIK2 IDUA SEZ6L2 PPP3CB TBR1 CSMD1 MUSK SEZ6L | 3.72e-04 | 891 | 243 | 23 | GO:0007610 |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 3.94e-04 | 53 | 243 | 5 | GO:0034110 | |
| GeneOntologyCellularComponent | receptor complex | PSG1 PSG2 PSG3 PSG6 INSRR IL18RAP ITGB4 PSG8 PLXNB1 PLXNB3 FLNA GPR20 BIRC2 GRIA2 GRIK2 GRIK3 CR1 PEX5L CR1L CR2 TFR2 TLR10 CD3D MUSK | 8.64e-08 | 581 | 243 | 24 | GO:0043235 |
| GeneOntologyCellularComponent | basal part of cell | ABCA1 PSG1 PSG2 PSG3 PSG6 CD46 ITGB4 MPP4 PROM2 DSTYK KCNJ10 PKD1 PSG8 SLC23A1 ABCC1 CR1 CR1L AQP4 | 5.04e-07 | 378 | 243 | 18 | GO:0045178 |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 8.01e-07 | 16 | 243 | 5 | GO:0070021 | |
| GeneOntologyCellularComponent | basal plasma membrane | ABCA1 PSG1 PSG2 PSG3 PSG6 CD46 ITGB4 PROM2 DSTYK KCNJ10 PKD1 PSG8 SLC23A1 ABCC1 CR1 CR1L AQP4 | 9.38e-07 | 354 | 243 | 17 | GO:0009925 |
| GeneOntologyCellularComponent | basolateral plasma membrane | ABCA1 PSG1 PSG2 PSG3 PSG6 CD46 PROM2 DSTYK KCNJ10 PKD1 PSG8 ABCC1 CR1 CR1L AQP4 | 5.56e-06 | 320 | 243 | 15 | GO:0016323 |
| GeneOntologyCellularComponent | extracellular matrix | PRSS3 LAMA1 SPOCK2 CHI3L1 SSPOP ITGB4 SVEP1 BMP1 FCGBP HMCN2 DMBT1 HSPG2 FRAS1 PLOD3 ZAN NTN3 LAMA4 LAMB1 EDIL3 SNED1 EYS NCAN | 9.18e-06 | 656 | 243 | 22 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | PRSS3 LAMA1 SPOCK2 CHI3L1 SSPOP ITGB4 SVEP1 BMP1 FCGBP HMCN2 DMBT1 HSPG2 FRAS1 PLOD3 ZAN NTN3 LAMA4 LAMB1 EDIL3 SNED1 EYS NCAN | 9.62e-06 | 658 | 243 | 22 | GO:0030312 |
| GeneOntologyCellularComponent | lateral plasma membrane | 1.01e-05 | 90 | 243 | 8 | GO:0016328 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | PSG1 PSG2 PSG3 PSG6 INSRR IL18RAP ITGB4 PSG8 FLNA BIRC2 GRIA2 GRIK2 GRIK3 TFR2 CD3D | 1.61e-05 | 350 | 243 | 15 | GO:0098802 |
| GeneOntologyCellularComponent | external side of plasma membrane | ABCA1 PSG1 PSG2 PSG3 PSG6 LY6G6D PSG8 STAB2 GRIA2 CR1 CR1L CR2 AQP4 TFR2 CD1B CD3D LY75 MUSK | 3.97e-05 | 519 | 243 | 18 | GO:0009897 |
| GeneOntologyCellularComponent | adherens junction | KLHL24 AHI1 PSG1 PSG2 PSG3 PSG6 MPP4 PSG8 DSC2 PIP5K1C STXBP6 | 4.02e-05 | 212 | 243 | 11 | GO:0005912 |
| GeneOntologyCellularComponent | cell-cell junction | ILDR2 KLHL24 AHI1 PSG1 PSG2 PSG3 PSG6 LAMA1 NRXN1 MPP4 PSG8 FLNA DSC2 VSIG10 PIP5K1C AQP4 PPP3CA STXBP6 CSK | 6.70e-05 | 591 | 243 | 19 | GO:0005911 |
| GeneOntologyCellularComponent | basement membrane | 9.16e-05 | 122 | 243 | 8 | GO:0005604 | |
| GeneOntologyCellularComponent | cell surface | ABCA1 PSG1 PSG2 PSG3 PSG6 PSG7 CD46 ITGB4 LRFN4 LY6G6D NRXN1 PROM2 PKD1 PSG8 PLXNB3 LRFN1 STAB2 GRIA2 CR1 CR1L CR2 AQP4 TFR2 CD1B CD3D ROBO2 LY75 MUSK | 1.01e-04 | 1111 | 243 | 28 | GO:0009986 |
| GeneOntologyCellularComponent | ciliary membrane | 1.48e-04 | 98 | 243 | 7 | GO:0060170 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | PRSS3 LAMA1 SPOCK2 SSPOP ITGB4 BMP1 HMCN2 DMBT1 HSPG2 FRAS1 PLOD3 NTN3 LAMA4 LAMB1 EDIL3 EYS NCAN | 1.67e-04 | 530 | 243 | 17 | GO:0062023 |
| GeneOntologyCellularComponent | side of membrane | ABCA1 PSG1 PSG2 PSG3 PSG6 RYR1 LY6G6D SPACA4 PSG8 STAB2 BIRC2 GRIA2 HID1 CR1 CR1L CR2 AQP4 TFR2 CD1B CD3D PPP3CA LY75 MUSK | 2.39e-04 | 875 | 243 | 23 | GO:0098552 |
| GeneOntologyCellularComponent | perikaryon | CNTNAP3B KLHL24 CNTNAP3 FLNA AZIN2 CAMK2B GRIA2 GRIK2 GRIK3 PPP5C | 2.95e-04 | 223 | 243 | 10 | GO:0043204 |
| GeneOntologyCellularComponent | laminin-1 complex | 4.01e-04 | 3 | 243 | 2 | GO:0005606 | |
| GeneOntologyCellularComponent | anchoring junction | ILDR2 KLHL24 AHI1 PSG1 PSG2 PSG3 PSG6 LAMA1 CD46 ITGB4 NRXN1 MPP4 DSTYK PSG8 ESPN HSPG2 FLNA DSC2 VSIG10 PIP5K1C AQP4 PPP3CA STXBP6 CSK | 4.60e-04 | 976 | 243 | 24 | GO:0070161 |
| GeneOntologyCellularComponent | cell projection membrane | PSG1 PSG2 PSG3 PSG6 PDZK1 ADCY6 PROM2 PKD1 PSG8 GRIA2 PIP5K1C AQP4 MACF1 ROBO2 | 5.53e-04 | 431 | 243 | 14 | GO:0031253 |
| GeneOntologyCellularComponent | glutamatergic synapse | ITGB4 LRFN4 NRXN1 FLNA OGT COMT CAMK2B SLITRK4 CPEB3 GRIA2 DGKE NBEA GRIK2 GRIK3 PIP5K1C PPP3CA PPP3CB NCAN ROBO2 CADPS2 SEZ6L | 5.97e-04 | 817 | 243 | 21 | GO:0098978 |
| GeneOntologyCellularComponent | plasma membrane protein complex | PSG1 PSG2 PSG3 PSG6 INSRR IL18RAP SSPOP ITGB4 RYR1 PSG8 C6 C7 HSPG2 FLNA BIRC2 GRIA2 GRIK2 GRIK3 TFR2 CD3D | 8.97e-04 | 785 | 243 | 20 | GO:0098797 |
| GeneOntologyCellularComponent | synaptic membrane | ITGB4 LRFN4 NRXN1 MPP4 LRFN1 COMT GRIA2 NBEA GRIK2 GRIK3 PIP5K1C SLC6A5 ROBO2 CADPS2 MUSK SEZ6L | 1.37e-03 | 583 | 243 | 16 | GO:0097060 |
| GeneOntologyCellularComponent | kainate selective glutamate receptor complex | 1.96e-03 | 6 | 243 | 2 | GO:0032983 | |
| GeneOntologyCellularComponent | calcineurin complex | 1.96e-03 | 6 | 243 | 2 | GO:0005955 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 2.58e-06 | 17 | 193 | 5 | MP:0031047 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 7.45e-06 | 35 | 193 | 6 | MP:0031618 | |
| MousePheno | increased skeletal muscle triglyceride level | 8.10e-06 | 21 | 193 | 5 | MP:0031415 | |
| MousePheno | decreased muscle cell glucose uptake | 1.43e-05 | 39 | 193 | 6 | MP:0030022 | |
| MousePheno | decreased fatty acid oxidation | 1.64e-05 | 24 | 193 | 5 | MP:0014172 | |
| MousePheno | increased abdominal fat pad weight | 3.00e-05 | 27 | 193 | 5 | MP:0009286 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 3.62e-05 | 28 | 193 | 5 | MP:0020950 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 4.30e-05 | 47 | 193 | 6 | MP:0031617 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 6.04e-05 | 31 | 193 | 5 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 6.04e-05 | 31 | 193 | 5 | MP:0008964 | |
| MousePheno | ostium primum atrial septal defect | 7.28e-05 | 17 | 193 | 4 | MP:0010404 | |
| MousePheno | decreased cellular glucose uptake | 8.58e-05 | 53 | 193 | 6 | MP:0003926 | |
| MousePheno | abnormal muscle triglyceride level | 1.27e-04 | 36 | 193 | 5 | MP:0031412 | |
| MousePheno | decreased respiratory quotient | 1.41e-04 | 110 | 193 | 8 | MP:0010379 | |
| MousePheno | decreased susceptibility to viral infection induced morbidity/mortality | 1.73e-04 | 60 | 193 | 6 | MP:0009790 | |
| Domain | CCP | CD46 SVEP1 F13B HP C6 C7 CR1 CR1L CR2 SEZ6L2 SNED1 NCAN CSMD1 SEZ6L | 6.63e-15 | 54 | 246 | 14 | SM00032 |
| Domain | SUSHI | CD46 SVEP1 F13B HP C6 C7 CR1 CR1L CR2 SEZ6L2 SNED1 NCAN CSMD1 SEZ6L | 1.16e-14 | 56 | 246 | 14 | PS50923 |
| Domain | Sushi_SCR_CCP_dom | CD46 SVEP1 F13B HP C6 C7 CR1 CR1L CR2 SEZ6L2 SNED1 NCAN CSMD1 SEZ6L | 1.52e-14 | 57 | 246 | 14 | IPR000436 |
| Domain | Sushi | CD46 SVEP1 F13B HP C6 C7 CR1 CR1L CR2 SEZ6L2 NCAN CSMD1 SEZ6L | 1.05e-13 | 52 | 246 | 13 | PF00084 |
| Domain | EGF_1 | CNTNAP3B LAMA1 DNER CNTNAP3 SSPOP ITGB4 SVEP1 BMP1 HMCN2 NRXN1 C6 C7 HSPG2 STAB2 ZAN NTN3 LAMA4 LAMB1 EDIL3 SNED1 EYS NCAN | 3.41e-12 | 255 | 246 | 22 | PS00022 |
| Domain | EGF-like_dom | CNTNAP3B LAMA1 DNER CNTNAP3 SVEP1 BMP1 FCGBP HMCN2 NRXN1 C6 C7 HSPG2 FRAS1 STAB2 ZAN LAMA4 LAMB1 EDIL3 SNED1 EYS NCAN | 1.66e-11 | 249 | 246 | 21 | IPR000742 |
| Domain | EGF_2 | CNTNAP3B LAMA1 DNER CNTNAP3 SSPOP ITGB4 SVEP1 BMP1 HMCN2 NRXN1 C6 C7 HSPG2 STAB2 ZAN NTN3 LAMB1 EDIL3 SNED1 EYS NCAN | 5.39e-11 | 265 | 246 | 21 | PS01186 |
| Domain | EGF-like_CS | LAMA1 DNER CNTNAP3 ITGB4 SVEP1 BMP1 HMCN2 NRXN1 C6 C7 HSPG2 STAB2 ZAN NTN3 LAMA4 LAMB1 EDIL3 SNED1 EYS NCAN | 2.86e-10 | 261 | 246 | 20 | IPR013032 |
| Domain | IGc2 | PSG1 PSG2 PSG3 PSG6 PSG7 FSTL4 IGSF10 LRFN4 HMCN2 PXDNL PSG8 ROBO3 HSPG2 SDK2 LRFN1 VSIG10 WFIKKN1 ROBO2 MUSK | 3.27e-10 | 235 | 246 | 19 | SM00408 |
| Domain | Ig_sub2 | PSG1 PSG2 PSG3 PSG6 PSG7 FSTL4 IGSF10 LRFN4 HMCN2 PXDNL PSG8 ROBO3 HSPG2 SDK2 LRFN1 VSIG10 WFIKKN1 ROBO2 MUSK | 3.27e-10 | 235 | 246 | 19 | IPR003598 |
| Domain | - | ILDR2 PSG1 PSG2 PSG3 PSG6 PSG7 INSRR FSTL4 IL18RAP ITGB4 IGSF10 LRFN4 FCAR PXDNL PSG8 ROBO3 KIR2DS3 PLXNB1 PLXNB3 HSPG2 FLNA SDK2 LRFN1 VSIG10 SNED1 CD1B CD3D WFIKKN1 NCAN ROBO2 MUSK | 9.61e-10 | 663 | 246 | 31 | 2.60.40.10 |
| Domain | Ig-like_fold | ILDR2 PSG1 PSG2 PSG3 PSG6 PSG7 INSRR FSTL4 IL18RAP ITGB4 IGSF10 LRFN4 FCAR HMCN2 PXDNL PSG8 ROBO3 KIR2DS3 PLXNB1 PLXNB3 HSPG2 FLNA SDK2 LRFN1 VSIG10 SNED1 CD1B CD3D WFIKKN1 NCAN ROBO2 MUSK | 1.08e-09 | 706 | 246 | 32 | IPR013783 |
| Domain | IG | ILDR2 PSG1 PSG2 PSG3 PSG6 PSG7 FSTL4 IL18RAP IGSF10 LRFN4 FCAR HMCN2 PXDNL PSG8 ROBO3 KIR2DS3 HSPG2 SDK2 LRFN1 VSIG10 WFIKKN1 NCAN ROBO2 MUSK | 1.91e-09 | 421 | 246 | 24 | SM00409 |
| Domain | Ig_sub | ILDR2 PSG1 PSG2 PSG3 PSG6 PSG7 FSTL4 IL18RAP IGSF10 LRFN4 FCAR HMCN2 PXDNL PSG8 ROBO3 KIR2DS3 HSPG2 SDK2 LRFN1 VSIG10 WFIKKN1 NCAN ROBO2 MUSK | 1.91e-09 | 421 | 246 | 24 | IPR003599 |
| Domain | EGF | CNTNAP3B LAMA1 DNER CNTNAP3 SVEP1 BMP1 FCGBP NRXN1 HSPG2 FRAS1 STAB2 ZAN LAMA4 LAMB1 EDIL3 SNED1 EYS NCAN | 2.31e-09 | 235 | 246 | 18 | SM00181 |
| Domain | Ig-like_dom | ILDR2 PSG1 PSG2 PSG3 PSG6 PSG7 FSTL4 IL18RAP IGSF10 LRFN4 FCAR HMCN2 PXDNL PSG8 ROBO3 KIR2DS3 HSPG2 SDK2 LRFN1 VSIG10 CD1B CD3D WFIKKN1 NCAN ROBO2 MUSK | 3.07e-09 | 503 | 246 | 26 | IPR007110 |
| Domain | IG_LIKE | ILDR2 PSG1 PSG2 PSG3 PSG6 PSG7 FSTL4 IL18RAP IGSF10 LRFN4 FCAR HMCN2 PXDNL PSG8 ROBO3 KIR2DS3 HSPG2 SDK2 LRFN1 VSIG10 CD1B WFIKKN1 NCAN ROBO2 MUSK | 8.51e-09 | 491 | 246 | 25 | PS50835 |
| Domain | EGF_3 | CNTNAP3B DNER CNTNAP3 SSPOP SVEP1 BMP1 HMCN2 NRXN1 C6 C7 HSPG2 STAB2 ZAN EDIL3 SNED1 EYS NCAN | 1.53e-08 | 235 | 246 | 17 | PS50026 |
| Domain | EGF | DNER CNTNAP3 SVEP1 BMP1 NRXN1 HSPG2 STAB2 ZAN EDIL3 SNED1 EYS NCAN | 1.08e-07 | 126 | 246 | 12 | PF00008 |
| Domain | Ig_I-set | PSG2 FSTL4 IGSF10 LRFN4 HMCN2 PXDNL ROBO3 HSPG2 SDK2 LRFN1 VSIG10 WFIKKN1 ROBO2 MUSK | 2.35e-07 | 190 | 246 | 14 | IPR013098 |
| Domain | I-set | PSG2 FSTL4 IGSF10 LRFN4 HMCN2 PXDNL ROBO3 HSPG2 SDK2 LRFN1 VSIG10 WFIKKN1 ROBO2 MUSK | 2.35e-07 | 190 | 246 | 14 | PF07679 |
| Domain | LAM_G_DOMAIN | 5.63e-07 | 38 | 246 | 7 | PS50025 | |
| Domain | Laminin_G_2 | 8.13e-07 | 40 | 246 | 7 | PF02210 | |
| Domain | Growth_fac_rcpt_ | LAMA1 INSRR DNER SVEP1 BMP1 HMCN2 HSPG2 FRAS1 STAB2 NTN3 LAMB1 EYS | 1.10e-06 | 156 | 246 | 12 | IPR009030 |
| Domain | ConA-like_dom | CNTNAP3B LAMA1 CNTNAP3 ITGB4 SVEP1 RYR1 NRXN1 HSPG2 ZAN LAMA4 NBEA TRIM68 EYS LRBA | 1.31e-06 | 219 | 246 | 14 | IPR013320 |
| Domain | LamG | 1.60e-06 | 44 | 246 | 7 | SM00282 | |
| Domain | EGF_LAM_2 | 2.24e-06 | 30 | 246 | 6 | PS50027 | |
| Domain | EGF_LAM_1 | 2.24e-06 | 30 | 246 | 6 | PS01248 | |
| Domain | - | 4.52e-06 | 95 | 246 | 9 | 2.60.120.200 | |
| Domain | EGF_CA | 4.96e-06 | 122 | 246 | 10 | SM00179 | |
| Domain | Ig_2 | 5.19e-06 | 73 | 246 | 8 | PF13895 | |
| Domain | EGF-like_Ca-bd_dom | 5.74e-06 | 124 | 246 | 10 | IPR001881 | |
| Domain | EGF_Lam | 5.79e-06 | 35 | 246 | 6 | SM00180 | |
| Domain | ASX_HYDROXYL | 6.92e-06 | 100 | 246 | 9 | PS00010 | |
| Domain | ig | PSG1 PSG2 PSG3 PSG6 PSG7 FSTL4 FCAR PSG8 KIR2DS3 HSPG2 SDK2 VSIG10 | 8.55e-06 | 190 | 246 | 12 | PF00047 |
| Domain | Immunoglobulin | PSG1 PSG2 PSG3 PSG6 PSG7 FSTL4 FCAR PSG8 KIR2DS3 HSPG2 SDK2 VSIG10 | 8.55e-06 | 190 | 246 | 12 | IPR013151 |
| Domain | Laminin_EGF | 9.53e-06 | 38 | 246 | 6 | IPR002049 | |
| Domain | Laminin_G | 1.07e-05 | 58 | 246 | 7 | IPR001791 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.11e-05 | 106 | 246 | 9 | IPR000152 | |
| Domain | Ig_V-set | ILDR2 PSG1 PSG2 PSG3 PSG6 PSG7 IGSF10 PSG8 HSPG2 VSIG10 NCAN ROBO2 | 1.36e-05 | 199 | 246 | 12 | IPR013106 |
| Domain | hEGF | 2.92e-05 | 28 | 246 | 5 | PF12661 | |
| Domain | LDLRA_1 | 3.79e-05 | 48 | 246 | 6 | PS01209 | |
| Domain | EGF_Ca-bd_CS | 4.26e-05 | 97 | 246 | 8 | IPR018097 | |
| Domain | LDLRA_2 | 4.28e-05 | 49 | 246 | 6 | PS50068 | |
| Domain | EGF_CA | 4.93e-05 | 99 | 246 | 8 | PS01187 | |
| Domain | Laminin_EGF | 8.95e-05 | 35 | 246 | 5 | PF00053 | |
| Domain | VWC_out | 9.74e-05 | 19 | 246 | 4 | SM00215 | |
| Domain | Kazal_2 | 1.03e-04 | 36 | 246 | 5 | PF07648 | |
| Domain | VWC | 1.34e-04 | 38 | 246 | 5 | SM00214 | |
| Domain | FA58C_3 | 1.47e-04 | 21 | 246 | 4 | PS50022 | |
| Domain | FA58C | 1.47e-04 | 21 | 246 | 4 | SM00231 | |
| Domain | FA58C_1 | 1.47e-04 | 21 | 246 | 4 | PS01285 | |
| Domain | FA58C_2 | 1.47e-04 | 21 | 246 | 4 | PS01286 | |
| Domain | V-set | 1.69e-04 | 184 | 246 | 10 | PF07686 | |
| Domain | LDLR_class-A_CS | 1.72e-04 | 40 | 246 | 5 | IPR023415 | |
| Domain | DUF1088 | 1.73e-04 | 2 | 246 | 2 | PF06469 | |
| Domain | DUF1088 | 1.73e-04 | 2 | 246 | 2 | IPR010508 | |
| Domain | Cys-rich_flank_reg_C | 1.86e-04 | 90 | 246 | 7 | IPR000483 | |
| Domain | LRRCT | 1.86e-04 | 90 | 246 | 7 | SM00082 | |
| Domain | VWF_dom | 2.18e-04 | 42 | 246 | 5 | IPR001007 | |
| Domain | Galactose-bd-like | 2.44e-04 | 94 | 246 | 7 | IPR008979 | |
| Domain | F5_F8_type_C | 2.54e-04 | 24 | 246 | 4 | PF00754 | |
| Domain | FA58C | 2.54e-04 | 24 | 246 | 4 | IPR000421 | |
| Domain | Ldl_recept_a | 3.03e-04 | 45 | 246 | 5 | PF00057 | |
| Domain | KAZAL | 3.36e-04 | 46 | 246 | 5 | SM00280 | |
| Domain | Fol_N | 3.44e-04 | 11 | 246 | 3 | IPR003645 | |
| Domain | Laminin_G_1 | 3.44e-04 | 11 | 246 | 3 | PF00054 | |
| Domain | FOLN | 3.44e-04 | 11 | 246 | 3 | SM00274 | |
| Domain | LDLa | 4.52e-04 | 49 | 246 | 5 | SM00192 | |
| Domain | CUB | 4.52e-04 | 49 | 246 | 5 | PF00431 | |
| Domain | LDrepeatLR_classA_rpt | 4.52e-04 | 49 | 246 | 5 | IPR002172 | |
| Domain | C8 | 4.55e-04 | 12 | 246 | 3 | PF08742 | |
| Domain | TIL | 4.55e-04 | 12 | 246 | 3 | PF01826 | |
| Domain | Metallophos | 4.69e-04 | 28 | 246 | 4 | PF00149 | |
| Domain | Calcineurin-like_PHP_ApaH | 4.69e-04 | 28 | 246 | 4 | IPR004843 | |
| Domain | KAZAL_2 | 4.97e-04 | 50 | 246 | 5 | PS51465 | |
| Domain | CUB | 4.97e-04 | 50 | 246 | 5 | SM00042 | |
| Domain | TILa | 5.14e-04 | 3 | 246 | 2 | PF12714 | |
| Domain | TILa_dom | 5.14e-04 | 3 | 246 | 2 | IPR025615 | |
| Domain | Kazal_dom | 5.46e-04 | 51 | 246 | 5 | IPR002350 | |
| Domain | PP2Ac | 5.86e-04 | 13 | 246 | 3 | SM00156 | |
| Domain | Ser/Thr-sp_prot-phosphatase | 5.86e-04 | 13 | 246 | 3 | IPR006186 | |
| Domain | C8 | 5.86e-04 | 13 | 246 | 3 | SM00832 | |
| Domain | SER_THR_PHOSPHATASE | 5.86e-04 | 13 | 246 | 3 | PS00125 | |
| Domain | Unchr_dom_Cys-rich | 5.86e-04 | 13 | 246 | 3 | IPR014853 | |
| Domain | - | 5.97e-04 | 52 | 246 | 5 | 2.60.120.290 | |
| Domain | Metallo-depent_PP-like | 6.15e-04 | 30 | 246 | 4 | IPR029052 | |
| Domain | - | 6.15e-04 | 30 | 246 | 4 | 3.60.21.10 | |
| Domain | CUB | 6.52e-04 | 53 | 246 | 5 | PS01180 | |
| Domain | TIL_dom | 7.38e-04 | 14 | 246 | 3 | IPR002919 | |
| Domain | CUB_dom | 9.12e-04 | 57 | 246 | 5 | IPR000859 | |
| Domain | FIMAC | 1.02e-03 | 4 | 246 | 2 | SM00057 | |
| Domain | FacI_MAC | 1.02e-03 | 4 | 246 | 2 | IPR003884 | |
| Domain | VWF_type-D | 1.11e-03 | 16 | 246 | 3 | IPR001846 | |
| Domain | LamNT | 1.11e-03 | 16 | 246 | 3 | SM00136 | |
| Domain | Laminin_N | 1.11e-03 | 16 | 246 | 3 | IPR008211 | |
| Domain | VWFD | 1.11e-03 | 16 | 246 | 3 | PS51233 | |
| Domain | VWD | 1.11e-03 | 16 | 246 | 3 | SM00216 | |
| Domain | LAMININ_NTER | 1.11e-03 | 16 | 246 | 3 | PS51117 | |
| Domain | Laminin_N | 1.11e-03 | 16 | 246 | 3 | PF00055 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 4.35e-05 | 30 | 188 | 5 | M27216 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 4.41e-05 | 188 | 188 | 11 | MM15828 | |
| Pathway | WP_COMPLEMENT_AND_COAGULATION_CASCADES | 1.18e-04 | 58 | 188 | 6 | M39649 | |
| Pathway | WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES | 1.30e-04 | 59 | 188 | 6 | M48343 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.30e-04 | 59 | 188 | 6 | M27218 | |
| Pubmed | PRSS3 KDM4C DNER SPOCK2 KPNA6 PKD1 MAP3K11 BACE2 MED13 PLXNB3 ACTR8 CFAP91 OGT TTC28 CLIP2 POLR2C HECTD4 LAMB1 BIRC2 NBEA TRIM68 PRPF8 EDIL3 VPS9D1 PPP3CA PPP3CB PPP5C MACF1 LRBA CADPS2 SMAD2 SEZ6L | 9.11e-10 | 1285 | 248 | 32 | 35914814 | |
| Pubmed | 6.03e-09 | 36 | 248 | 7 | 37497580 | ||
| Pubmed | 1.25e-08 | 5 | 248 | 4 | 2377620 | ||
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 2.18e-08 | 13 | 248 | 5 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 2.18e-08 | 13 | 248 | 5 | 19273835 | |
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 20044046 | ||
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 32150576 | ||
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 6265583 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 2.18e-08 | 13 | 248 | 5 | 12832451 | |
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 25406283 | ||
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 8380065 | ||
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 1279194 | ||
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 25724769 | ||
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 2.18e-08 | 13 | 248 | 5 | 22092845 | |
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 2.18e-08 | 13 | 248 | 5 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 2.18e-08 | 13 | 248 | 5 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 2.18e-08 | 13 | 248 | 5 | 23800882 | |
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 19285068 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 2.18e-08 | 13 | 248 | 5 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 2.18e-08 | 13 | 248 | 5 | 39168268 | |
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 8402684 | ||
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 2.18e-08 | 13 | 248 | 5 | 21949477 | |
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 26219866 | ||
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 2133556 | ||
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 19621080 | ||
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 2.18e-08 | 13 | 248 | 5 | 19358828 | |
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 16680193 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 2.18e-08 | 13 | 248 | 5 | 34058224 | |
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 10964771 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 2.18e-08 | 13 | 248 | 5 | 23935487 | |
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 2.18e-08 | 13 | 248 | 5 | 25972571 | |
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 2.18e-08 | 13 | 248 | 5 | 15220458 | |
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 18843289 | ||
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 15207636 | ||
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 21081647 | ||
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 11133662 | ||
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 11483763 | ||
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 18003729 | ||
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 20739537 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 2.18e-08 | 13 | 248 | 5 | 27695943 | |
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 20404914 | ||
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 2.18e-08 | 13 | 248 | 5 | 16638824 | |
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 34440862 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 2.18e-08 | 13 | 248 | 5 | 21670291 | |
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 22162753 | ||
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 2702644 | ||
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 11801635 | ||
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 21760897 | ||
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 1719235 | ||
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 16619040 | ||
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 2.18e-08 | 13 | 248 | 5 | 8209741 | |
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 32521208 | ||
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 19406938 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 2.18e-08 | 13 | 248 | 5 | 29967450 | |
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 1653760 | ||
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 32169849 | ||
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 2.18e-08 | 13 | 248 | 5 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 2.18e-08 | 13 | 248 | 5 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 2.18e-08 | 13 | 248 | 5 | 15316023 | |
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 15331748 | ||
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 2.18e-08 | 13 | 248 | 5 | 22406619 | |
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 7628460 | ||
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 19008452 | ||
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 2164599 | ||
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 29396368 | ||
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 2.18e-08 | 13 | 248 | 5 | 33352461 | |
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 38381498 | ||
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 1633107 | ||
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 2.18e-08 | 13 | 248 | 5 | 32027621 | |
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 2.18e-08 | 13 | 248 | 5 | 27777319 | |
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 18848945 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | PDZK1 GSTO2 PTER RYR1 NIT2 BTG2 FCGBP HP PROM2 PKD1 BHMT2 SLC23A1 FKBP5 NAA16 HSPG2 FLNA PLOD3 DSC2 COMT AHCTF1 ABCC11 CR1 EYS CSK TKT ROBO2 | 2.25e-08 | 1016 | 248 | 26 | 19056867 |
| Pubmed | PSG1 PSG2 PSG3 PSG6 FSTL4 IGSF10 LRFN4 LY6G6D PSG8 ROBO3 LRFN1 | 2.69e-08 | 162 | 248 | 11 | 25826454 | |
| Pubmed | 3.36e-08 | 14 | 248 | 5 | 37531413 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 3.36e-08 | 14 | 248 | 5 | 34666041 | |
| Pubmed | 3.36e-08 | 14 | 248 | 5 | 34619794 | ||
| Pubmed | 3.36e-08 | 14 | 248 | 5 | 8896983 | ||
| Pubmed | 3.36e-08 | 14 | 248 | 5 | 22962327 | ||
| Pubmed | 3.36e-08 | 14 | 248 | 5 | 17623671 | ||
| Pubmed | 3.36e-08 | 14 | 248 | 5 | 26846848 | ||
| Pubmed | CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. | 3.36e-08 | 14 | 248 | 5 | 18794798 | |
| Pubmed | 3.36e-08 | 14 | 248 | 5 | 23469261 | ||
| Pubmed | 3.36e-08 | 14 | 248 | 5 | 18454175 | ||
| Pubmed | 3.36e-08 | 14 | 248 | 5 | 29907459 | ||
| Pubmed | 3.36e-08 | 14 | 248 | 5 | 36719377 | ||
| Pubmed | 3.36e-08 | 14 | 248 | 5 | 28567513 | ||
| Pubmed | 3.36e-08 | 14 | 248 | 5 | 8207827 | ||
| Pubmed | 3.36e-08 | 14 | 248 | 5 | 19700760 | ||
| Pubmed | 3.36e-08 | 14 | 248 | 5 | 9212243 | ||
| Pubmed | 3.36e-08 | 14 | 248 | 5 | 1648219 | ||
| Interaction | FBXO2 interactions | CNTNAP3B EMC1 LAMA1 CNTNAP3 BMP1 LRFN4 HSPG2 FRAS1 SDK2 PLOD3 MAN2B2 DSC2 LAMA4 LAMB1 IDUA EDIL3 SEZ6L2 SNED1 | 3.12e-06 | 411 | 245 | 18 | int:FBXO2 |
| Interaction | GRIK3 interactions | 4.23e-06 | 10 | 245 | 4 | int:GRIK3 | |
| Cytoband | 19q13.2 | 3.34e-05 | 164 | 248 | 7 | 19q13.2 | |
| Cytoband | 7q22 | 5.31e-05 | 38 | 248 | 4 | 7q22 | |
| Cytoband | 1q32 | 1.45e-04 | 49 | 248 | 4 | 1q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q32 | 1.97e-04 | 290 | 248 | 8 | chr1q32 | |
| Cytoband | 19q13.1 | 2.28e-04 | 55 | 248 | 4 | 19q13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | CEBPA PSG1 PSG2 PSG3 PSG6 PSG7 RYR1 TULP2 FCGBP FCAR SPACA4 PSG8 ZNF417 ACP7 LRFN1 PPP5C SBK2 | 2.97e-04 | 1192 | 248 | 17 | chr19q13 |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | CD46 SVEP1 F13B HP C6 C7 CR1 CR1L CR2 SEZ6L2 SNED1 NCAN CSMD1 SEZ6L | 1.22e-16 | 57 | 169 | 14 | 1179 |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 2.71e-10 | 11 | 169 | 6 | 1315 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | FSTL4 IGSF10 LRFN4 HMCN2 PXDNL ROBO3 HSPG2 SDK2 LRFN1 VSIG10 WFIKKN1 ROBO2 MUSK | 3.77e-09 | 161 | 169 | 13 | 593 |
| GeneFamily | Complement system|Sushi domain containing | 9.42e-07 | 36 | 169 | 6 | 492 | |
| GeneFamily | Immunoglobulin like domain containing | 8.59e-05 | 193 | 169 | 9 | 594 | |
| GeneFamily | Fibronectin type III domain containing | 1.32e-04 | 160 | 169 | 8 | 555 | |
| GeneFamily | Laminin subunits | 1.66e-04 | 12 | 169 | 3 | 626 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 2.14e-04 | 13 | 169 | 3 | 693 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 7.41e-04 | 115 | 169 | 6 | 769 | |
| GeneFamily | Glutamate ionotropic receptor kainate type subunits | 8.53e-04 | 5 | 169 | 2 | 1199 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 8.65e-04 | 163 | 169 | 7 | 590 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.22e-03 | 394 | 169 | 11 | 471 | |
| GeneFamily | BTG/Tob family | 1.27e-03 | 6 | 169 | 2 | 1309 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 1.41e-03 | 24 | 169 | 3 | 654 | |
| GeneFamily | SPARC family | 2.34e-03 | 8 | 169 | 2 | 1278 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 2.99e-03 | 9 | 169 | 2 | 1230 | |
| GeneFamily | Plexins | 2.99e-03 | 9 | 169 | 2 | 683 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 3.72e-03 | 10 | 169 | 2 | 53 | |
| GeneFamily | ATP binding cassette subfamily C | 6.33e-03 | 13 | 169 | 2 | 807 | |
| Coexpression | NABA_CORE_MATRISOME | SPOCK1 LAMA1 SPOCK2 SSPOP SVEP1 IGSF10 HMCN2 PXDNL DMBT1 HSPG2 FRAS1 NTN3 LAMA4 LAMB1 EDIL3 SNED1 EYS NCAN | 1.54e-10 | 275 | 247 | 18 | M5884 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | LAMA1 SSPOP SVEP1 IGSF10 HMCN2 PXDNL DMBT1 FRAS1 NTN3 LAMA4 LAMB1 EDIL3 SNED1 EYS | 5.80e-09 | 196 | 247 | 14 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | SPOCK1 LAMA1 SPOCK2 SSPOP SVEP1 IGSF10 HMCN2 DMBT1 HSPG2 FRAS1 NTN3 LAMA4 LAMB1 EDIL3 SNED1 NCAN | 6.89e-09 | 270 | 247 | 16 | MM17057 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | LAMA1 SSPOP SVEP1 IGSF10 HMCN2 DMBT1 FRAS1 NTN3 LAMA4 LAMB1 EDIL3 SNED1 | 2.93e-07 | 191 | 247 | 12 | MM17059 |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 3.21e-07 | 48 | 247 | 7 | MM531 | |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 4.86e-07 | 32 | 247 | 6 | MM2 | |
| Coexpression | GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_UP | INSRR SPOCK2 MAP3K3 BTG1 FRAS1 BIRC2 IDUA SEZ6L2 ZFHX4 CARF SLC6A5 | 2.78e-06 | 196 | 247 | 11 | M4532 |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | 3.55e-06 | 201 | 247 | 11 | MM1294 | |
| Coexpression | NABA_MATRISOME | PRSS3 SPOCK1 LAMA1 SPOCK2 SSPOP SVEP1 F13B IGSF10 BMP1 HMCN2 PXDNL DMBT1 PLXNB1 PLXNB3 HSPG2 FRAS1 PLOD3 NRTN NTN3 LAMA4 LAMB1 EDIL3 SNED1 EYS WFIKKN1 NCAN | 5.05e-06 | 1026 | 247 | 26 | M5889 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | SPOCK1 DNER SPOCK2 ANO5 DHX33 SSPOP MDN1 NRXN1 CAMK2B DUSP4 SLITRK4 CPEB3 GRIA2 DGKE NBEA GRIK2 GRIK3 PEX5L SEZ6L2 ZFPM2 PPP3CB ZFHX4 NCAN ROBO2 CSMD1 SEZ6L MAP3K2 | 6.51e-06 | 1106 | 247 | 27 | M39071 |
| Coexpression | ZHANG_UTERUS_C1_REGENERATIVE_UP | GALNT3 PSG1 PSG2 PSG3 PSG6 TXNRD1 BTG2 TXNDC5 PSG8 BACE2 NRTN CR1 CR1L | 6.53e-06 | 302 | 247 | 13 | MM16604 |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 1.84e-05 | 35 | 247 | 5 | MM757 | |
| Coexpression | GSE20715_0H_VS_6H_OZONE_LUNG_DN | 2.16e-05 | 200 | 247 | 10 | M4365 | |
| Coexpression | LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN | 2.81e-05 | 7 | 247 | 3 | M7057 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP | 3.00e-05 | 128 | 247 | 8 | MM1000 | |
| Coexpression | MURARO_PANCREAS_ALPHA_CELL | AHI1 PDZK1 DNER CD46 BTG2 NRXN1 OGT CAMK2B HECTD4 SLC35G2 EDIL3 SEZ6L2 SNED1 PPP3CB STXBP6 SEZ6L FBXW7 | 3.10e-05 | 568 | 247 | 17 | M39168 |
| Coexpression | GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN | 3.11e-05 | 167 | 247 | 9 | M361 | |
| Coexpression | NABA_MATRISOME | PRSS3 SPOCK1 LAMA1 SPOCK2 SSPOP SVEP1 F13B IGSF10 BMP1 HMCN2 DMBT1 PLXNB1 PLXNB3 HSPG2 FRAS1 PLOD3 NRTN NTN3 LAMA4 LAMB1 EDIL3 SNED1 WFIKKN1 NCAN | 3.25e-05 | 1008 | 247 | 24 | MM17056 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 3.59e-05 | 40 | 247 | 5 | M5887 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | 4.39e-05 | 135 | 247 | 8 | MM965 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_MYELOID_CELL_AGEING | 4.68e-05 | 219 | 247 | 10 | MM3826 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 6.09e-05 | 182 | 247 | 9 | MM993 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_DEFINITIVE_ERYTHROBLAST | 7.05e-05 | 24 | 247 | 4 | M45748 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_3_4WK_UP | 7.06e-05 | 230 | 247 | 10 | MM986 | |
| Coexpression | GSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_DN | 7.29e-05 | 145 | 247 | 8 | M359 | |
| Coexpression | CYCLIN_D1_KE_.V1_UP | 7.81e-05 | 188 | 247 | 9 | M2648 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRN | NRXN1 ROBO3 DUSP4 CPEB3 GRIA2 GRIK2 PEX5L EDIL3 SEZ6L2 ZFHX4 NCAN ROBO2 | 8.81e-05 | 335 | 247 | 12 | M39065 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | DNER FSTL4 NRXN1 MAP3K11 CAMK2B SLITRK4 DGKE GRIK2 GRIK3 EDIL3 SEZ6L2 TFR2 ROBO2 CSMD1 SEZ6L | 1.01e-04 | 506 | 247 | 15 | M39067 |
| Coexpression | GSE25088_WT_VS_STAT6_KO_MACROPHAGE_DN | 1.20e-04 | 199 | 247 | 9 | M8031 | |
| Coexpression | GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_DN | 1.25e-04 | 200 | 247 | 9 | M5808 | |
| Coexpression | GSE2826_WT_VS_BTK_KO_BCELL_UP | 1.25e-04 | 200 | 247 | 9 | M4898 | |
| Coexpression | GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_UP | 1.25e-04 | 200 | 247 | 9 | M8436 | |
| Coexpression | GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_UP | 1.25e-04 | 200 | 247 | 9 | M3675 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | SPOCK1 DNER ANO5 NRXN1 CAMK2B SLITRK4 CPEB3 GRIA2 DGKE NBEA GRIK2 PEX5L EDIL3 SEZ6L2 PPP3CB ZFHX4 ROBO2 CSMD1 | 1.34e-04 | 703 | 247 | 18 | M39070 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | DNER NRXN1 DUSP4 SLITRK4 CPEB3 GRIA2 DGKE NBEA SEZ6L2 ZFPM2 ZFHX4 PLPP2 NCAN ROBO2 | 1.47e-04 | 465 | 247 | 14 | M39066 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | SPOCK1 DNER GAB2 NRXN1 CAMK2B DUSP4 SLITRK4 CPEB3 NBEA GRIK3 SEZ6L2 ZFHX4 ROBO2 CSMD1 CADPS2 SEZ6L | 1.48e-04 | 584 | 247 | 16 | M39068 |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | ILDR2 INSRR DNER BTG2 NRXN1 ANXA2R KCNJ10 ROBO3 ESPN ACP7 CFAP91 AZIN2 CAMK2B DUSP4 LAMB1 GRIA2 GRIK3 CR2 STXBP6 SLC6A5 LRBA TBR1 MAPK4 CSMD1 | 1.54e-04 | 1115 | 247 | 24 | M10371 |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | ABCA1 ADCY6 IGSF10 BTG2 ABCC1 COMT TTC28 CAMK2B DUSP4 LAMB1 GRIA2 NBEA CR2 DIP2C MACF1 SARAF TBR1 LY75 | 1.82e-04 | 721 | 247 | 18 | M1999 |
| Coexpression | HEVNER_INTERMEDIATE_ZONE_AND_UP_POSTMITOTIC_PROJECTION_NEURONS | 2.00e-04 | 57 | 247 | 5 | MM415 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS | 2.53e-04 | 93 | 247 | 6 | M40279 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | KDM4C INSRR SPOCK2 TXNRD1 BMP1 LRFN4 NRXN1 BACE2 FRAS1 SDK2 PEX5L SEZ6L | 2.85e-10 | 174 | 247 | 12 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | CNTNAP3B CNTNAP3 ANO5 NRXN1 BCL2L10 CAMK2B GRIA2 GRIK2 PEX5L KLHDC8A SEZ6L | 8.97e-09 | 188 | 247 | 11 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 |
| ToppCell | facs-Pancreas-Endocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | INSRR SPOCK2 BLK BTG2 NRXN1 BTG1 BACE2 TTC28 SEZ6L2 SARAF SEZ6L | 9.48e-09 | 189 | 247 | 11 | 010fdd70e9d0e21b856306a29ff877776a480319 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA1 INSRR NRXN1 FNIP1 BACE2 TTC28 NBEA SEZ6L2 MACF1 ROBO2 SEZ6L | 1.31e-08 | 195 | 247 | 11 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | AHI1 INSRR SPOCK2 BMP1 BACE2 TTC28 SEZ6L2 AQP4 ROBO2 GPR45 SEZ6L | 1.31e-08 | 195 | 247 | 11 | bd8e24dd598990204998d1dd853ba7a53dc0107e |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA1 INSRR NRXN1 FNIP1 BACE2 TTC28 NBEA SEZ6L2 MACF1 ROBO2 SEZ6L | 1.31e-08 | 195 | 247 | 11 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ABCA1 LAMA1 CHI3L1 SVEP1 IGSF10 PXDNL C7 SDK2 LAMA4 LAMB1 MACF1 | 1.62e-08 | 199 | 247 | 11 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | ILDR2 CHI3L1 SVEP1 HP FRAS1 DSC2 LAMA4 GRIA2 GRIK2 SEZ6L2 ZFPM2 | 1.70e-08 | 200 | 247 | 11 | c800f20adedf4ca736c740510889e92d8bf0ba44 |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Mesothelial-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | ILDR2 CHI3L1 SVEP1 HP FRAS1 DSC2 LAMA4 GRIA2 GRIK2 SEZ6L2 ZFPM2 | 1.70e-08 | 200 | 247 | 11 | bf50e30d5cafb71c567e89580f62084d2f894170 |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | ABCA1 LAMA1 CHI3L1 SVEP1 PXDNL C7 SDK2 TTC28 LAMA4 LAMB1 MACF1 | 1.70e-08 | 200 | 247 | 11 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | ILDR2 CHI3L1 SVEP1 HP FRAS1 DSC2 LAMA4 GRIA2 GRIK2 SEZ6L2 ZFPM2 | 1.70e-08 | 200 | 247 | 11 | 5e5ad07679d5dd2ca80249bce9aaf4a95d42187b |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.29e-08 | 178 | 247 | 10 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TULP2 NRXN1 KCNJ10 PLXNB3 CAMK2B GRIA2 GRIK2 GRIK3 PEX5L CSMD1 | 8.17e-08 | 183 | 247 | 10 | 2cf36ad89584eb9f8b04de52a1b511b7f3527884 |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TULP2 NRXN1 KCNJ10 PLXNB3 CAMK2B GRIA2 GRIK2 GRIK3 PEX5L CSMD1 | 8.17e-08 | 183 | 247 | 10 | 98fee6838acfaee5e2e449ba088764ec06b8bc57 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-08 | 184 | 247 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-08 | 184 | 247 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-08 | 184 | 247 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-07 | 188 | 247 | 10 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-07 | 191 | 247 | 10 | 3387b95a3f2445c672d407922fdce3a91eabaef8 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-07 | 191 | 247 | 10 | a251b134f67a0a1ef3a42f50042f128a17f20b22 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.32e-07 | 146 | 247 | 9 | cffa91d76606f74553d81150adbb23b003746316 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.63e-07 | 197 | 247 | 10 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.87e-07 | 200 | 247 | 10 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.87e-07 | 200 | 247 | 10 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.87e-07 | 200 | 247 | 10 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-07 | 159 | 247 | 9 | fd7db2f7328cfefdc3ada2af91006d5a91d137e1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-07 | 159 | 247 | 9 | aaf449c768d6fbb0a1bb47746ff3bdb7f9eb8914 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-07 | 159 | 247 | 9 | 8bbdef1e927f3130b578d7d7c5ff38bbe06fab63 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-07 | 174 | 247 | 9 | a0ccda8fd6f55251cdeff24cf66e72e4a31d2104 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.11e-07 | 175 | 247 | 9 | 8362a46f5804333baa84cd56d450bc147f372a7e | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.11e-07 | 175 | 247 | 9 | 8b4c62e608f0ec84e563bbf0ebffe3ed44085298 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.73e-07 | 180 | 247 | 9 | 9e09b3dfe344b5d50520711513d389865d73a861 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.73e-07 | 180 | 247 | 9 | dad458398683ff80a6e207bdc08e257d1bb757d6 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.73e-07 | 180 | 247 | 9 | d9c9399df3e2d9f23dbbfffb6cbe8404bf01e2b7 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 8.48e-07 | 182 | 247 | 9 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.48e-07 | 182 | 247 | 9 | 812ff2a50a510b18d865e89465dba1754a08ef61 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.88e-07 | 183 | 247 | 9 | 848fc6dd129150897ee339343e83c645b6e779eb | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.02e-06 | 186 | 247 | 9 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-06 | 186 | 247 | 9 | ea936e66ae4b7b40564711fad60ac0137327995f | |
| ToppCell | droplet-Pancreas|droplet / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-06 | 187 | 247 | 9 | 5f4df092452d8672bda4059c794e099ba3f5a8fa | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.06e-06 | 187 | 247 | 9 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.11e-06 | 188 | 247 | 9 | 2db80767903703e7e0a1a37c598f7877a909ee94 | |
| ToppCell | Severe-MAIT|Severe / Disease group and Cell class | 1.21e-06 | 190 | 247 | 9 | 1c063dc1b62d9f9912aaf8d0297555a6545f5550 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-06 | 191 | 247 | 9 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-PNEC-PNEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.27e-06 | 191 | 247 | 9 | 146cfd4daa2878536b4f381564c787919ad855a8 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.27e-06 | 191 | 247 | 9 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-PNEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.27e-06 | 191 | 247 | 9 | 12ea07565dc0e62cade9fbab4a2d763e47a341e3 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.27e-06 | 191 | 247 | 9 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-06 | 192 | 247 | 9 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-06 | 192 | 247 | 9 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 1.32e-06 | 192 | 247 | 9 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.32e-06 | 192 | 247 | 9 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-06 | 193 | 247 | 9 | 027e098ad018e782287f84eee0f77551018f2196 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-06 | 193 | 247 | 9 | c5463a87f20b3a7f7ffda677b2f5a0e9e49d6685 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.38e-06 | 193 | 247 | 9 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 1.44e-06 | 194 | 247 | 9 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-06 | 194 | 247 | 9 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-06 | 194 | 247 | 9 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.50e-06 | 195 | 247 | 9 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 1.50e-06 | 195 | 247 | 9 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-CFuPNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.50e-06 | 195 | 247 | 9 | 574354ef4bcefeb9856b65d19bb92e2cffe5dc7a | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.50e-06 | 195 | 247 | 9 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-06 | 196 | 247 | 9 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | Bronchial-NucSeq-Stromal-Schwann|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.57e-06 | 196 | 247 | 9 | a90c76d9c57a4491b94a321ba541b792ec5d8e83 | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-06 | 196 | 247 | 9 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | COPD-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 1.57e-06 | 196 | 247 | 9 | c9bdd505c3ab380ed7b272aa518df31a0a706a06 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 1.64e-06 | 197 | 247 | 9 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | Bronchial-NucSeq-Stromal-Schwann-Schwann_nonmyelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-06 | 197 | 247 | 9 | 4a7ff67bb0754e034e6f2a1bd34cde86ee3ef899 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.64e-06 | 197 | 247 | 9 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 1.64e-06 | 197 | 247 | 9 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.64e-06 | 197 | 247 | 9 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.71e-06 | 198 | 247 | 9 | 8f25e8dff42bad8e779ca618bdb1cb1610667962 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.71e-06 | 198 | 247 | 9 | e3e0aa3ef20b2370f5b133048510677aaa562dfa | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.78e-06 | 199 | 247 | 9 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.78e-06 | 199 | 247 | 9 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.78e-06 | 199 | 247 | 9 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.78e-06 | 199 | 247 | 9 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.85e-06 | 200 | 247 | 9 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Mesothelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 1.85e-06 | 200 | 247 | 9 | 553386523fd8f8f36617a0d81032224b7ddce442 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.85e-06 | 200 | 247 | 9 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.85e-06 | 200 | 247 | 9 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.85e-06 | 200 | 247 | 9 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.85e-06 | 200 | 247 | 9 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.85e-06 | 200 | 247 | 9 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 3.06e-06 | 159 | 247 | 8 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.36e-06 | 161 | 247 | 8 | e3327c296d48e821004e61a573abb75624a6f040 | |
| ToppCell | LPS_only-Unknown-Endothelial-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.65e-06 | 115 | 247 | 7 | c67145d3cd9243994a141749b426ff2a6dcc8d93 | |
| ToppCell | LPS_only-Unknown-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.65e-06 | 115 | 247 | 7 | ad5298c2ad8bf94fa13c2e50b0799e929473ef59 | |
| ToppCell | LPS_only-Unknown|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.65e-06 | 115 | 247 | 7 | 7a733f6987b40ec497a03734b79ed5355ad3a2fc | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.85e-06 | 164 | 247 | 8 | be49af6335f2505065cde2cb9800e4a5516811b1 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 3.85e-06 | 164 | 247 | 8 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 4.03e-06 | 165 | 247 | 8 | 3d2acdae0dd2b79a15f74158e8e566ce22b4218e | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Exhausted_Tfh|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 4.21e-06 | 166 | 247 | 8 | c73fce59256ad501864f44f76cfae2fc33b3777e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.40e-06 | 167 | 247 | 8 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.60e-06 | 168 | 247 | 8 | e870d2e69316406f45112ed0bf324b24f902a99e | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.60e-06 | 168 | 247 | 8 | 403aba73a0f9ffb32252288d075fad8a588ca440 | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.24e-06 | 171 | 247 | 8 | e59afa0a773dca3b9c208d17510ea55703b42598 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 6.21e-06 | 175 | 247 | 8 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 6.21e-06 | 175 | 247 | 8 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | COPD-Epithelial-PNEC|Epithelial / Disease state, Lineage and Cell class | 7.33e-06 | 179 | 247 | 8 | 988d0853c391da1e5004f73f3678047418d3f6d3 | |
| Computational | Neighborhood of EGFR | 4.66e-06 | 32 | 151 | 6 | GNF2_EGFR | |
| Computational | Neighborhood of IGFBP1 | 8.07e-06 | 35 | 151 | 6 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MMP11 | 2.40e-05 | 42 | 151 | 6 | GNF2_MMP11 | |
| Computational | Neighborhood of CDKN1C | 3.22e-05 | 27 | 151 | 5 | GNF2_CDKN1C | |
| Computational | Neighborhood of TIMP2 | 4.10e-05 | 46 | 151 | 6 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 5.91e-05 | 49 | 151 | 6 | GNF2_KISS1 | |
| Drug | Nabumetone [42924-53-8]; Up 200; 17.6uM; MCF7; HT_HG-U133A | SVEP1 RYR1 FCAR RMND5A CAMK2B LAMA4 PMEL TFR2 SNED1 PPP5C WIPI2 SEZ6L | 1.93e-06 | 198 | 248 | 12 | 6487_UP |
| Disease | Autistic Disorder | AHI1 NRXN1 ROBO3 COMT LAMB1 NBEA GRIK2 SEZ6L2 AQP4 STXBP6 ROBO2 TBR1 CADPS2 | 2.12e-07 | 261 | 236 | 13 | C0004352 |
| Disease | cD177 antigen measurement | 2.47e-07 | 18 | 236 | 5 | EFO_0021866 | |
| Disease | Schizophrenia | ABCA1 AHI1 PDZK1 LAMA1 CHI3L1 HDAC3 TXNDC5 NRXN1 HP BTG1 COMT CAMK2B GRIA2 SRR GRIK2 GRIK3 AQP4 NCAN SLC6A5 CSMD1 CADPS2 | 9.75e-06 | 883 | 236 | 21 | C0036341 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.24e-05 | 152 | 236 | 8 | DOID:0060041 (implicated_via_orthology) | |
| Disease | triacylglycerol 56:7 measurement | 8.10e-05 | 29 | 236 | 4 | EFO_0010434 | |
| Disease | lymphocyte count | CEBPA PSG1 SLC38A9 INSRR DNER RIPOR3 IL18RAP HORMAD1 ADCY5 GAB2 DDX60L DMBT1 FKBP5 ABCC1 FRAS1 RMND5A ZAN TTC28 HECTD4 SLC35G2 ZFPM2 TFR2 PPP5C PLPP2 CSK ROBO2 | 1.26e-04 | 1464 | 236 | 26 | EFO_0004587 |
| Disease | Malignant neoplasm of breast | PDZK1 BMP1 HP SLC10A6 KLHDC7A PLEKHA8 PLXNB1 KPNA5 ABCC1 FLNA COMT BIRC2 DGKE GRIK2 GRIK3 SLC6A5 DIP2C MACF1 LRBA GPR45 FBXW7 | 1.61e-04 | 1074 | 236 | 21 | C0006142 |
| Disease | peripheral arterial disease, traffic air pollution measurement | 1.79e-04 | 194 | 236 | 8 | EFO_0004265, EFO_0007908 | |
| Disease | body fat percentage, fasting blood glucose measurement | 1.90e-04 | 3 | 236 | 2 | EFO_0004465, EFO_0007800 | |
| Disease | Mental Depression | 2.22e-04 | 254 | 236 | 9 | C0011570 | |
| Disease | obesity (implicated_via_orthology) | 3.58e-04 | 215 | 236 | 8 | DOID:9970 (implicated_via_orthology) | |
| Disease | Schizophrenia | 3.77e-04 | 18 | 236 | 3 | cv:C0036341 | |
| Disease | Vesico-Ureteral Reflux | 3.78e-04 | 4 | 236 | 2 | C0042580 | |
| Disease | Depressive disorder | 5.68e-04 | 289 | 236 | 9 | C0011581 | |
| Disease | Affective Disorders, Psychotic | 6.27e-04 | 5 | 236 | 2 | C0001723 | |
| Disease | response to platinum based chemotherapy, cytotoxicity measurement | 6.27e-04 | 5 | 236 | 2 | EFO_0004647, EFO_0006952 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 8.59e-04 | 53 | 236 | 4 | C4707243 | |
| Disease | body mass index, osteoarthritis | 9.22e-04 | 54 | 236 | 4 | EFO_0004340, MONDO_0005178 | |
| Disease | dietary heme iron intake measurement, type 2 diabetes mellitus | 9.35e-04 | 6 | 236 | 2 | EFO_0008355, MONDO_0005148 | |
| Disease | CD97 antigen measurement | 9.35e-04 | 6 | 236 | 2 | EFO_0020250 | |
| Disease | carbonic anhydrase 4 measurement | 9.35e-04 | 6 | 236 | 2 | EFO_0020230 | |
| Disease | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | 9.35e-04 | 6 | 236 | 2 | C3888239 | |
| Disease | procollagen C-endopeptidase enhancer 1 measurement | 9.35e-04 | 6 | 236 | 2 | EFO_0801920 | |
| Disease | Lissencephaly | 9.35e-04 | 6 | 236 | 2 | C0266463 | |
| Disease | erythrocyte aggregation | 9.35e-04 | 6 | 236 | 2 | EFO_0803375 | |
| Disease | HOMA-B | 9.88e-04 | 55 | 236 | 4 | EFO_0004469 | |
| Disease | severe acute respiratory syndrome, COVID-19 | ZFYVE1 NRXN1 SLC23A1 ATP8B3 EDIL3 ZFPM2 GCNT7 EYS PPP5C CSMD1 CADPS2 | 1.02e-03 | 447 | 236 | 11 | EFO_0000694, MONDO_0100096 |
| Disease | paracentral lobule volume measurement | 1.02e-03 | 25 | 236 | 3 | EFO_0010317 | |
| Disease | level of Sterol ester (27:1/16:0) in blood serum | 1.15e-03 | 26 | 236 | 3 | OBA_2045191 | |
| Disease | blood manganese measurement | 1.28e-03 | 27 | 236 | 3 | EFO_0007581 | |
| Disease | blood sedimentation | 1.30e-03 | 7 | 236 | 2 | EFO_0004304 | |
| Disease | pleckstrin homology domain-containing family A member 1 measurement | 1.30e-03 | 7 | 236 | 2 | EFO_0802873 | |
| Disease | calcineurin subunit B type 1 measurement | 1.30e-03 | 7 | 236 | 2 | EFO_0020215 | |
| Disease | bacterial meningitis (is_marker_for) | 1.30e-03 | 7 | 236 | 2 | DOID:9470 (is_marker_for) | |
| Disease | myoclonic-atonic epilepsy (implicated_via_orthology) | 1.30e-03 | 7 | 236 | 2 | DOID:0060475 (implicated_via_orthology) | |
| Disease | Dental enamel hypoplasia, dental caries, tooth agenesis | 1.30e-03 | 7 | 236 | 2 | EFO_0003819, EFO_0005410, EFO_1001304 | |
| Disease | lumbar disc degeneration | 1.43e-03 | 28 | 236 | 3 | EFO_0004994 | |
| Disease | urate measurement, bone density | PSG2 MTG2 DNER RIPOR3 DHX33 DMBT1 SLC23A1 FRAS1 TTC28 AHCTF1 SFMBT2 EYS CADPS2 | 1.55e-03 | 619 | 236 | 13 | EFO_0003923, EFO_0004531 |
| Disease | hair morphology | 1.58e-03 | 29 | 236 | 3 | EFO_0005038 | |
| Disease | Unilateral agenesis of kidney | 1.73e-03 | 8 | 236 | 2 | C0266294 | |
| Disease | retinal vein occlusion (biomarker_via_orthology) | 1.73e-03 | 8 | 236 | 2 | DOID:1727 (biomarker_via_orthology) | |
| Disease | focal segmental glomerulosclerosis (is_marker_for) | 1.73e-03 | 8 | 236 | 2 | DOID:1312 (is_marker_for) | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 1.73e-03 | 8 | 236 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | melanocyte protein PMEL measurement | 1.73e-03 | 8 | 236 | 2 | EFO_0801792 | |
| Disease | non-high density lipoprotein cholesterol measurement | ABCA1 GALK2 CEBPA PSG1 PSG3 HP DSTYK FKBP5 COMT POR GRIK2 PPP5C NCAN MUSK | 1.93e-03 | 713 | 236 | 14 | EFO_0005689 |
| Disease | eye colour measurement | 1.94e-03 | 218 | 236 | 7 | EFO_0009764 | |
| Disease | low tension glaucoma | 2.21e-03 | 9 | 236 | 2 | EFO_1001022 | |
| Disease | apolipoprotein D measurement | 2.21e-03 | 9 | 236 | 2 | EFO_0020156 | |
| Disease | C3 glomerulopathy | 2.21e-03 | 9 | 236 | 2 | C4087273 | |
| Disease | kallikrein-14 measurement | 2.21e-03 | 9 | 236 | 2 | EFO_0020513 | |
| Disease | Complement deficiency disease | 2.31e-03 | 33 | 236 | 3 | C0272242 | |
| Disease | lifestyle measurement, alcohol consumption measurement | 2.36e-03 | 115 | 236 | 5 | EFO_0007878, EFO_0010724 | |
| Disease | temporal horn of lateral ventricle volume measurement | 2.68e-03 | 72 | 236 | 4 | EFO_0010333 | |
| Disease | Atypical Hemolytic Uremic Syndrome | 2.75e-03 | 10 | 236 | 2 | C2931788 | |
| Disease | tropomyosin beta chain measurement | 2.75e-03 | 10 | 236 | 2 | EFO_0020787 | |
| Disease | 3-phenylpropionate hydrocinnamate measurement | 2.75e-03 | 10 | 236 | 2 | EFO_0021010 | |
| Disease | linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] measurement | 2.75e-03 | 10 | 236 | 2 | EFO_0800499 | |
| Disease | triacylglycerol 56:8 measurement | 2.97e-03 | 36 | 236 | 3 | EFO_0010435 | |
| Disease | multiple myeloma (is_marker_for) | 2.97e-03 | 36 | 236 | 3 | DOID:9538 (is_marker_for) | |
| Disease | psychosocial stress measurement | 3.34e-03 | 11 | 236 | 2 | EFO_0006783 | |
| Disease | Hemolytic-Uremic Syndrome | 3.34e-03 | 11 | 236 | 2 | C0019061 | |
| Disease | level of Sterol ester (27:1/20:5) in blood serum | 3.34e-03 | 11 | 236 | 2 | OBA_2045197 | |
| Disease | tumor necrosis factor receptor superfamily member 11B measurement | 3.34e-03 | 11 | 236 | 2 | EFO_0020801 | |
| Disease | SCHIZOPHRENIA | 3.34e-03 | 11 | 236 | 2 | 181500 | |
| Disease | basophil count, eosinophil count | 3.39e-03 | 241 | 236 | 7 | EFO_0004842, EFO_0005090 | |
| Disease | basophil percentage of leukocytes | 3.55e-03 | 243 | 236 | 7 | EFO_0007992 | |
| Disease | mean corpuscular hemoglobin concentration | CEBPA PSG1 NDUFS2 BTG2 JOSD1 PARP9 SLC23A1 MED13 ABCC1 RMND5A TTC28 HECTD4 TFR2 NCAN MACF1 LY75 MUSK WIPI2 | 3.57e-03 | 1105 | 236 | 18 | EFO_0004528 |
| Disease | tea consumption measurement | 3.87e-03 | 129 | 236 | 5 | EFO_0010091 | |
| Disease | Hereditary hemochromatosis | 3.99e-03 | 12 | 236 | 2 | C0392514 | |
| Disease | tyrosine-protein kinase ZAP-70 measurement | 3.99e-03 | 12 | 236 | 2 | EFO_0020833 | |
| Disease | serine protease 27 measurement | 3.99e-03 | 12 | 236 | 2 | EFO_0008280 | |
| Disease | linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2] measurement | 3.99e-03 | 12 | 236 | 2 | EFO_0800500 | |
| Disease | complement component C7 measurement | 3.99e-03 | 12 | 236 | 2 | EFO_0008093 | |
| Disease | Hemochromatosis | 3.99e-03 | 12 | 236 | 2 | C0018995 | |
| Disease | granulocyte count | 4.51e-03 | 254 | 236 | 7 | EFO_0007987 | |
| Disease | Common variable immunodeficiency | 4.69e-03 | 13 | 236 | 2 | cv:C0009447 | |
| Disease | complement component C6 measurement | 4.69e-03 | 13 | 236 | 2 | EFO_0020281 | |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 4.69e-03 | 13 | 236 | 2 | DOID:332 (biomarker_via_orthology) | |
| Disease | homostachydrine measurement | 4.69e-03 | 13 | 236 | 2 | EFO_0021164 | |
| Disease | systemic scleroderma | 4.87e-03 | 85 | 236 | 4 | EFO_0000717 | |
| Disease | triacylglycerol 56:6 measurement | 4.92e-03 | 43 | 236 | 3 | EFO_0010433 | |
| Disease | birth weight | 5.07e-03 | 399 | 236 | 9 | EFO_0004344 | |
| Disease | cognitive impairment measurement | 5.25e-03 | 44 | 236 | 3 | EFO_0007998 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 5.44e-03 | 14 | 236 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | Alzheimer disease, visuospatial impairment | 5.44e-03 | 14 | 236 | 2 | EFO_0009752, MONDO_0004975 | |
| Disease | glycodeoxycholate measurement | 5.44e-03 | 14 | 236 | 2 | EFO_0010493 | |
| Disease | Bladder Neoplasm | 5.46e-03 | 140 | 236 | 5 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 5.63e-03 | 141 | 236 | 5 | C0005684 | |
| Disease | metabolite measurement | 5.72e-03 | 560 | 236 | 11 | EFO_0004725 | |
| Disease | ovarian serous carcinoma | 5.95e-03 | 46 | 236 | 3 | EFO_1001516 | |
| Disease | obsolete_red blood cell distribution width | KLHL24 AHI1 PSG1 CD46 ZFYVE1 BTG2 DSTYK SLC23A1 SEC14L4 ABCC1 OGT TTC28 HECTD4 SLC35G2 HEXD CR1L ZFPM2 TFR2 LPIN2 MUSK | 6.05e-03 | 1347 | 236 | 20 | EFO_0005192 |
| Disease | Alzheimer disease, Cognitive impairment | 6.24e-03 | 15 | 236 | 2 | HP_0100543, MONDO_0004975 | |
| Disease | smoking status measurement, carotid artery intima media thickness | 6.70e-03 | 48 | 236 | 3 | EFO_0006527, EFO_0007117 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 7.10e-03 | 49 | 236 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | fetal genotype effect measurement, body weights and measures | 7.10e-03 | 49 | 236 | 3 | EFO_0004324, EFO_0007959 | |
| Disease | birth weight, pelvic organ prolapse | 7.10e-03 | 49 | 236 | 3 | EFO_0004344, EFO_0004710 | |
| Disease | acute myeloid leukemia (is_marker_for) | 7.10e-03 | 49 | 236 | 3 | DOID:9119 (is_marker_for) | |
| Disease | level of triacylglycerol (56:6) in blood serum | 7.10e-03 | 16 | 236 | 2 | OBA_2020007 | |
| Disease | Spondyloepiphyseal Dysplasia | 7.10e-03 | 16 | 236 | 2 | C0038015 | |
| Disease | diabetic retinopathy (implicated_via_orthology) | 7.10e-03 | 16 | 236 | 2 | DOID:8947 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AVLAGGLYEYVFCPD | 241 | P55087 | |
| GAGLNYECYRFGISP | 386 | Q9Y5Z0 | |
| DPRGIYRCNGTDIYK | 66 | P04234 | |
| VLIDSGDTYYFGGCL | 481 | Q9BZ76 | |
| IVYYILSRCPFGIED | 216 | Q75V66 | |
| GQSVSFECYPGYILI | 2106 | Q96PZ7 | |
| LLLADYLGYCAREPG | 21 | Q9HD36 | |
| AACASRDGYPIILYE | 626 | Q8N157 | |
| LGDCYYCVSGLPEAR | 426 | O43306 | |
| LVGEEALYVNPLDCY | 166 | Q9H981 | |
| EGCGVDIFAELGRYY | 266 | Q96A70 | |
| LPTRFAVYYGARGCL | 106 | Q99678 | |
| AAACGGIIYFTLYLP | 746 | O95477 | |
| LYEGYGQSETVVICA | 366 | Q6NUN0 | |
| GVRYFECPALQGIFT | 126 | Q9UDT6 | |
| VRESTNYPGDYTLCV | 106 | P41240 | |
| ENIVPTEYYSGEGCL | 436 | O60306 | |
| TEYYSGEGCLALPKL | 441 | O60306 | |
| IRNTDTCYGLVIYAG | 341 | O60423 | |
| YEYVECPIRGTAAEN | 61 | P53701 | |
| LGDCYYCVSGLPEAR | 516 | O95622 | |
| YETCPRYLLGVLNAG | 181 | P29016 | |
| ESSTLIGRYCGYEKP | 501 | P13497 | |
| YPVLGEYSLDSCDLG | 41 | Q3ZCQ2 | |
| FYVERDTGNLYCTRP | 186 | Q02487 | |
| CGYRESLVLPIYEGI | 141 | Q9NZ32 | |
| DYASQVYGPLSRLGC | 366 | Q7Z4T9 | |
| INPYCALIEEAYGLD | 466 | O15131 | |
| GRYLVYICFRNGEEE | 1576 | Q9ULI1 | |
| GLYAIGYEECIERPL | 421 | Q6P1R3 | |
| YIGLSCQDCAPGYTR | 1536 | P98160 | |
| LPYKCSETGALGENY | 46 | Q8IXQ6 | |
| RSSIYGRPGACYVDI | 156 | Q9UJ83 | |
| TQPRLCYLVKEGGSY | 131 | Q5T2W1 | |
| LEYCPGGELFDYIIS | 86 | Q14680 | |
| GLGYASDETVLFRYC | 116 | Q99748 | |
| LLPGVQYVYRCGSAQ | 101 | Q6ZNF0 | |
| YEGGGCRFLRYDCVI | 686 | O60568 | |
| REEQCILYLGPRYGF | 211 | Q13451 | |
| SGVNPYCGLIEEAYG | 461 | O60684 | |
| YGYSLCLLERDVAPG | 446 | O95256 | |
| CYDPGQHVFLVYGER | 1966 | Q9NU22 | |
| PAGSCSYDGVVRYQD | 281 | Q86XX4 | |
| ICNEGYYLIGEEILY | 126 | P15529 | |
| YIGRLCVVNVDYCLG | 596 | Q5T1H1 | |
| PRGYTGAYCEKSIDN | 1106 | Q5T1H1 | |
| CLPSKDYAEVGRVGY | 266 | P00738 | |
| YGFRYISEECPLAIV | 131 | P78508 | |
| EVGETLLYYGCRRSD | 556 | P16435 | |
| DCIASVYGYDLGGRF | 6 | P31152 | |
| CGDRTHPGYLAYEEI | 171 | Q8NDA2 | |
| GRAYDLCVLAVYDDG | 486 | Q9P244 | |
| TGDYYRQLGRCPGET | 516 | B1AK53 | |
| YYCSGRQREAAPVSE | 271 | Q8WW38 | |
| IGDSYRGYCVSETEL | 216 | Q8N187 | |
| YLVECYLVDLLSNGG | 66 | Q5H9U9 | |
| AGTLAYYEICDFLRG | 291 | P36222 | |
| YIEFICRGDTYPAEL | 611 | P05160 | |
| CRGDTYPAELYITGS | 616 | P05160 | |
| LEGNERYEGYCVDLA | 436 | P42262 | |
| GPVDLNVSGIYRCYG | 181 | P24071 | |
| LACRYVSEVVIGAPY | 276 | Q99447 | |
| YVELPLACEGGRYGL | 261 | O43157 | |
| CLYAFLREVAGEPLY | 1461 | Q9ULL4 | |
| VDYFDYCPELGRVSL | 421 | Q9BW27 | |
| YNLGISCINLGAYRE | 546 | Q8IYB4 | |
| CISAYQRLGRYGDAL | 491 | Q6N069 | |
| IIGEHIDYCGYSVLP | 46 | Q01415 | |
| SVIACEYLDDAYPGR | 86 | Q9H4Y5 | |
| AFGRVYLCYDVDTGR | 366 | Q9Y2U5 | |
| GDVNYLFEGVCYGPL | 266 | Q96J66 | |
| QRLHIGCDEVYYLGE | 141 | Q8WVB3 | |
| LFYGRDVNGVCLLYD | 41 | Q96JB8 | |
| CGISIEGVNTPYLYF | 166 | Q9H3R0 | |
| GYIEDCYVPQRSIYD | 26 | O94854 | |
| LRCYVNGELASYGEI | 316 | P50851 | |
| EIYTRDGNSYGRPCE | 156 | O60449 | |
| ERCLAGYYGDPIIGS | 896 | P07942 | |
| RQDLAGTYRCYGSVP | 91 | Q14952 | |
| ICVREVGGAYYNLDS | 141 | Q15040 | |
| LLCGGILSYYDSPED | 21 | Q96JA3 | |
| LNYGYVGCIRDLFID | 636 | Q9ULB1 | |
| TLVNAPYKRGFYCGD | 26 | O43688 | |
| LALGKEARACPYYGS | 341 | Q96FC9 | |
| GGVVCFFPSYEYLRQ | 701 | Q96FC9 | |
| YCGQRLSPYLEDVSG | 2096 | Q9Y4D8 | |
| TNGEITAYEVCYGLV | 1246 | P16144 | |
| QELGRGQYGVVYLCD | 656 | Q6XUX3 | |
| QCVLGYTELPADRAY | 181 | Q9Y5Y3 | |
| YYCLNVPLRDGIDDQ | 216 | O15379 | |
| FDVPVGSRGDCYDRY | 316 | O75306 | |
| GLVYPSEGIQASVCY | 186 | Q5TIA1 | |
| QLGCYLEYDLFGTEL | 246 | Q96BW5 | |
| PYSYAATDLQVGGRC | 241 | O00634 | |
| TIYDAGFPDQGRYEC | 566 | A1KZ92 | |
| LGGALCQYEDVISPY | 176 | Q9BRQ4 | |
| IATPLGNVEECYRYF | 156 | A1A4V9 | |
| VLLELGAYCGYSAVR | 111 | P21964 | |
| EGLYCGTRDCYEVLG | 41 | Q9H1X3 | |
| YGTVRYGALELCVPA | 161 | O60755 | |
| ISEAYRGDTFIGYVC | 91 | O43854 | |
| EVTARYCGRELEQYG | 6 | Q9BSY4 | |
| GYYRCVAANPSGVDF | 641 | Q6WRI0 | |
| CERVGGFNLPYTECY | 321 | Q6TFL4 | |
| LQYRSGEGAVDACYR | 371 | Q53HC5 | |
| AREAYNLGVRYIGGC | 276 | Q9H2M3 | |
| ILYSCDQGYLLVGEA | 876 | P20023 | |
| FETVGYQYFRCLPDG | 676 | P13671 | |
| EVFYSCEPGYDLRGA | 321 | P17927 | |
| EVFYSCEPGYDLRGA | 771 | P17927 | |
| EVFYSCEPGYDLRGA | 1221 | P17927 | |
| RLYGGVCYAGIDTDP | 571 | Q8NE35 | |
| GRYVEDICVYGPGDL | 356 | Q6ZNI0 | |
| GCLHDDRYYPLGQTF | 2391 | Q9Y6R7 | |
| GSCGVAYVVQEPGDY | 2291 | P21333 | |
| YGCAAAGYLDGRLEP | 131 | P49715 | |
| DAGERPCLQGYYTAA | 91 | Q14435 | |
| LGGYCSSYVPDFVLQ | 1001 | Q8TF40 | |
| CLDEGGYYISPRITF | 181 | P51451 | |
| GQEVFYSCEPGYDLR | 311 | Q2VPA4 | |
| SYVPVCGSDGRFYEN | 96 | Q6MZW2 | |
| KEYIQAGYSSPRGCL | 166 | Q9H9V9 | |
| VYTCNEGYSLIGNPV | 596 | P10643 | |
| CVQYDGRRVVSGAYD | 506 | Q969H0 | |
| PGRGQDSLVDYYFLC | 246 | A6NJJ6 | |
| PGIDLIAAFYGCLYA | 1036 | Q9Y2E4 | |
| AGREDSGICYRLYTE | 406 | Q9H6R0 | |
| PELTALGSFYLYCGQ | 371 | Q8TBE0 | |
| PGQVFVLDEYCARYG | 671 | Q86UW7 | |
| YVTRYLDNGLCSPDG | 471 | P35475 | |
| AGRYLVPVANDCYIV | 576 | Q9Y2E5 | |
| SGVDYRGVLACLDGY | 26 | P62312 | |
| LLSFYYSPECRGARG | 1256 | P14616 | |
| LYAIGGECLNSVERY | 591 | Q5VTJ3 | |
| RVYCSLLETGGQVYA | 21 | Q8IYD2 | |
| SGQILYEGLEYCEER | 316 | Q8WYP5 | |
| FYLVDAEQGRLCGYR | 671 | Q8N766 | |
| GGLYEVDVTQGECYP | 261 | Q8NEL9 | |
| ITYLRGIFPECAYGT | 41 | Q86X24 | |
| GIFPECAYGTRYLDD | 46 | Q86X24 | |
| LLPYYSARVLVCGGD | 266 | P52429 | |
| SACGLGFVPVVYYSL | 21 | Q6DWJ6 | |
| KPLYGNDRFEGYCID | 451 | Q13002 | |
| LYGNDRFEGYCIDLL | 456 | Q13003 | |
| LPGYTGELCQSKIDY | 381 | Q8NFT8 | |
| YDLIRSGCVRDDTYG | 2316 | Q9UGM3 | |
| CLLKGGYERFSSEYP | 141 | Q13115 | |
| GIYVIVVNCSEGLDY | 1821 | Q9P225 | |
| GDYVDRGYFSIECVL | 126 | P16298 | |
| GGEVPKSYYLCEQVR | 261 | Q9UDX3 | |
| NGILEGYRLVYEPCS | 1751 | Q58EX2 | |
| LYEEVRPLGQGCYGR | 61 | P0C263 | |
| CGLEEPVSYRGVTYS | 71 | Q8TDM5 | |
| ACFYPNIGGIIRYSG | 496 | Q8NBW4 | |
| DSLCQAVRTLLGYGY | 1036 | P21817 | |
| LGDYVDRGYFSIECV | 116 | Q08209 | |
| PYRGIDCLAVAYGVA | 321 | Q16584 | |
| VLIDSGDTYYFGGCL | 481 | Q96NU0 | |
| NCLGILGEDTDYLIY | 171 | Q96EK7 | |
| GVTKYTAGPYECEIR | 206 | P11464 | |
| GAFGRVYLCYDVDTG | 371 | Q99759 | |
| CAVYDSGGYVQELGL | 3811 | P98161 | |
| TRSQYGLPEDAIVYC | 831 | O15294 | |
| GVTKYTAGPYECEIR | 206 | Q16557 | |
| PGYYGDARIAKNCAV | 226 | Q16363 | |
| ILFGCQLEEPYYRSV | 726 | P33527 | |
| GDVTYPAHRDCYLGD | 86 | O95868 | |
| CETYEYPQRGGESAG | 406 | Q9UQC2 | |
| LVDCEGYPRSDVDLY | 56 | O00233 | |
| LRSGEALNPEYYCGS | 351 | Q5T011 | |
| CIAYIRLTQYIDGQG | 616 | Q13554 | |
| YIGEAICETPSDLYG | 236 | Q8IW52 | |
| SLYEEQLGRLYCPVE | 326 | P52788 | |
| GARITYQCDPGYDIV | 766 | Q9BYH1 | |
| YQCDPGYDIVGSDTL | 771 | Q9BYH1 | |
| YGQLCERGLEELIDY | 21 | Q9H871 | |
| LQAAGCTGRPLGYYA | 526 | Q16650 | |
| FTYPGACEYLLVREA | 1031 | A2VEC9 | |
| GSILICLYESYFDPG | 661 | Q9BXR5 | |
| GISYVYGLQRFCEDI | 651 | Q9Y345 | |
| LRGSCGLEYNLDYTE | 126 | Q96BY9 | |
| DCGICYAYQLDGTIP | 306 | Q9NW38 | |
| PYQCEIRDRYGGIRS | 306 | Q00889 | |
| LSVLVVCYYQEAPFG | 146 | Q8TBE7 | |
| ELFGIRPDDYLYSLC | 146 | O60331 | |
| ECYGYALGDATRAIE | 76 | P53041 | |
| GVTKYTAGPYECEIR | 206 | Q9UQ74 | |
| ESCLSGYYRVDGILF | 721 | P25391 | |
| LARSESYIGGDCYIV | 2726 | Q8NFP9 | |
| SLLNTVCAYDPVGYG | 251 | Q8IV36 | |
| QELYDVYCFARELGG | 246 | O14594 | |
| NCYSGDTVIIFPGEY | 416 | Q9BZQ2 | |
| GVCFPLYYDQTEDIG | 571 | Q8WXD0 | |
| YFVDYRRVLVCGGNG | 71 | Q9H4K7 | |
| FDTPYCRVGLGICYD | 141 | Q9NQR4 | |
| CYLAYPGSATIGEVQ | 171 | Q9Y4P8 | |
| TVLTYQCEPGYELLG | 666 | Q6UXD5 | |
| CDILVAYSAYNPEVG | 171 | Q86UD7 | |
| LAIQAYGASIVYCEP | 116 | Q9GZT4 | |
| EPYGSQRDIAYVVLC | 1361 | Q9UHV7 | |
| GVTNYTAGPYECEIR | 206 | Q13046 | |
| VPLDCVLYRYGSFSV | 471 | P40967 | |
| TLYYECDPGYVLNGT | 2796 | Q4LDE5 | |
| STIIYQCEPGYELEG | 3261 | Q4LDE5 | |
| VVYSCNRGYSLEGPS | 3321 | Q4LDE5 | |
| LYIYCRPSSGNSGDV | 256 | Q8NGL0 | |
| PERFYYNVESCGSLR | 226 | P19387 | |
| LGCIFGTYQALYELP | 441 | Q495N2 | |
| LGAVALYACDRGYSL | 716 | Q8TER0 | |
| RAGFYYIGPGDRVAC | 206 | Q13490 | |
| VSYRIGEDGSICVLY | 111 | P62324 | |
| PYEVSYRIGEDGSIC | 106 | P78543 | |
| GDSDIPVIVYRCVDY | 966 | Q96P48 | |
| VLLYIGTCDNPDYLG | 106 | Q8WUX2 | |
| EGRRYCDPVVLTYQA | 1536 | A5YKK6 | |
| CISDLRAQIAGYLYG | 2116 | Q6P2Q9 | |
| RYLGIPGDKEYCISS | 316 | Q16881 | |
| GCPGAERNLLVYSYF | 16 | Q8TF32 | |
| LATGGQGEYLTYICL | 36 | Q8NFX7 | |
| LARGESYTCGYKPFR | 686 | Q86UP3 | |
| GNEYRAGTDEYPILS | 401 | Q6AZZ1 | |
| ELGAVCYEPNVLGYL | 386 | O00295 | |
| SYRVYCLLGDGELSE | 146 | P29401 | |
| LVGYARLCPGDHYEV | 211 | Q96MK2 | |
| GIIESIGDYYACARL | 331 | Q9UHI7 | |
| PTVGIYFITYEGLCR | 176 | Q8N413 | |
| RYEAGYVVCAVIAGL | 101 | Q8N271 | |
| GLYYCIITTPDDLEG | 141 | Q71H61 | |
| VRLYYIGGEVFAECL | 336 | Q15796 | |
| PDEGVYTCVARNYLG | 136 | Q96MS0 | |
| TECYDELGNRYQLPV | 106 | Q8WUN7 | |
| GQLLLLRYCGYGEDR | 101 | Q5VUG0 | |
| ERPYECREYGKSFGQ | 321 | Q8TAU3 | |
| GAFIPRCNEEGYYKA | 331 | Q08629 | |
| CLTIPVAFGVYVNYR | 171 | Q3KNW5 | |
| PNYIGDGFTCRGSIY | 1586 | Q8WWQ8 | |
| GSYVCVARNYLGEAV | 106 | Q9HCK4 | |
| GYVIECPNCGVVYRS | 506 | Q9HBF4 | |
| YAYRCGIAEAVGLPS | 471 | Q3C1V9 | |
| IVGGYTCEENSLPYQ | 81 | P35030 | |
| GCPGADRNLLVYSFY | 16 | Q9H8G1 | |
| RGRAYGNLGDCYEAL | 876 | Q96AY4 | |
| YNARPEDAGLYTCTA | 251 | Q96NZ8 | |
| PYGCEECGKSYRLIS | 361 | Q13105 | |
| VRGEVLEGSNAYYCE | 1846 | Q9UPU5 | |
| YCGSAAYASPEVLLG | 171 | Q9BXA6 | |
| LDEGYYICRADSPVG | 381 | Q8N0Z9 | |
| YELCSGNQVRGYPTL | 251 | Q8NBS9 | |
| GVTKYTAGPYECEIR | 206 | P11465 | |
| GYPYCAAAQELGLLV | 506 | Q9Y2B5 | |
| GYLIGEEGYCLTSLQ | 601 | Q9Y2B5 | |
| VYCPYSAIGNVTGEL | 231 | Q9UP52 | |
| GIFIPSCDEDGYYRK | 331 | Q92563 | |
| YGRPYRLSCVEAFAA | 156 | Q9UJK0 | |
| CLVYGDPHYVTFDGR | 1156 | Q9Y493 | |
| IPNLLGEGIYARYNC | 1136 | P35573 | |
| YDCGDGFYNPVTRVV | 121 | Q5VZ52 | |
| VYAYTQVGVPDCRIF | 816 | Q92539 | |
| LDLGDAGCYGYARRL | 586 | Q6PJG9 | |
| VIYYVRDGNILSCPE | 811 | O15146 |